This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
5463 |
4. Check minimum number of eventsNone |
5463 |
5. Include endpointsNone |
5463 |
6. Filter based on genotype QC (FinnGen only) |
5463 |
Control definitions (FinnGen only)
- Control exclude
- ASTHMA_NOS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Ethmoidectomy
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5463 | 3003 | 2460 |
| Unadjusted period prevalence (%) | 1.05 | 1.02 | 1.08 |
| Median age at first event (years) | 48.64 | 46.34 | 51.44 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4950
- Matched controls
- 49499
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ZXA10
NOMESCO Finland
Bilateral
4.9
323.0
1664
4615
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
+∞
323.0
4756
*
R03AC02
ATC
salbutamol; inhalant
3.4
323.0
3375
19057
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
170.5
323.0
3603
763
UDM02
NOMESCO Finland
Sinoscopy
53.1
323.0
1152
281
J45.9
ICD-10 Finland
Asthma, unspecified
5.2
323.0
1677
4430
DPA30
NOMESCO Finland
Sphenotomy
329.0
323.0
553
19
H02AB04
ATC
methylprednisolone; systemic
4.5
323.0
1368
3885
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
4.6
323.0
2039
6512
TDM10
NOMESCO Finland
Puncture of maxillary antrum
26.9
323.0
1275
629
J01AA02
ATC
doxycycline; systemic
4.8
323.0
4439
31821
J32.4
ICD-10 Finland
Chronic pansinusitis
179.7
323.0
1241
92
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.2
323.0
1854
5106
R03DC03
ATC
montelukast; oral
6.6
323.0
1935
4359
R01AD12
ATC
fluticasone furoate; nasal
4.6
323.0
2637
9875
R01AD09
ATC
mometasone; nasal
7.3
323.0
3862
16180
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
293.3
323.0
705
28
R01AD01
ATC
beclometasone; nasal
4.4
323.0
1474
4395
J33.0
ICD-10 Finland
Polyp of nasal cavity
55.3
323.0
1405
352
DHB50
NOMESCO Finland
Turbinoplasty
13.5
323.0
591
491
J01.0
ICD-10 Finland
Acute maxillary sinusitis
6.0
323.0
2401
6678
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
23.1
323.0
1099
603
J34.2
ICD-10 Finland
Deviated nasal septum
8.2
323.0
854
1229
J01FA10
ATC
azithromycin; systemic
3.8
323.0
3757
22426
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
27.5
323.0
816
353
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
4.7
323.0
3683
18822
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
189.1
323.0
808
51
DHB20
NOMESCO Finland
Polypectomy of internal nose
51.1
323.0
726
166
R01AD08
ATC
fluticasone; nasal
19.5
323.0
4033
9118
H02AB06
ATC
prednisolone; systemic
7.8
323.0
3902
15951
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
58.7
323.0
3131
1409
R01AD05
ATC
budesonide; nasal
6.3
323.0
987
1879
UDH02
NOMESCO Finland
Rhinopharyngoscopy
22.2
323.0
1864
1308
J33.8
ICD-10 Finland
Other polyp of sinus
88.7
323.0
1377
214
R01BA52
ATC
pseudoephedrine, combinations; oral
3.8
323.0
2488
10332
DJD20
NOMESCO Finland
Plastic repair of septum of nose
9.6
317.9
690
819
J01FA09
ATC
clarithromycin; systemic
3.3
312.7
2350
10735
R03BA05
ATC
fluticasone; inhalant
3.8
289.1
1498
5048
J31.0
ICD-10 Finland
Chronic rhinitis
5.6
266.7
857
1773
J33.9
ICD-10 Finland
Nasal polyp, unspecified
34.9
258.2
339
104
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.9
256.9
953
2310
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.1
252.9
1878
8170
R03AK07
ATC
formoterol and budesonide; inhalant
3.4
248.6
1517
5713
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.0
246.7
1140
3411
R01AD11
ATC
triamcinolone; nasal
4.8
244.0
916
2238
J32.1
ICD-10 Finland
Chronic frontal sinusitis
89.6
243.2
271
32
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.0
234.2
842
1958
J45.1
ICD-10 Finland
Nonallergic asthma
5.8
229.1
713
1402
ZXC95
NOMESCO Finland
Use of surgical navigator
22.4
221.7
329
157
J45
ICD-10 Finland
Asthma
4.5
218.9
878
2274
DNB10
NOMESCO Finland
Endonasal ethmoidectomy
+∞
216.2
206
*
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
24.8
215.7
310
133
J01.1
ICD-10 Finland
Acute frontal sinusitis
16.1
206.7
345
229
J01CA04
ATC
amoxicillin; systemic
3.3
203.0
4348
33953
R06AX27
ATC
desloratadine; oral
2.7
201.8
1849
8893
H02AB07
ATC
prednisone; oral
3.5
197.3
1093
3724
R06AE07
ATC
cetirizine; oral
2.5
196.9
2633
15573
J01FA15
ATC
telithromycin; oral
3.9
195.0
926
2778
R03BA02
ATC
budesonide; inhalant
3.1
187.4
1239
4787
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
8.4
177.5
413
533
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.2
171.5
440
659
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
12.9
169.5
310
254
R06AE09
ATC
levocetirizine; oral
3.1
167.5
1111
4257
R96
ICPC
Asthma
4.1
154.9
678
1864
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
154.2
1664
8471
DPW99
NOMESCO Finland
Other operation on frontal or sphenoidal sinus
202.6
151.7
157
8
R03AK08
ATC
formoterol and beclometasone; inhalant
6.4
149.2
419
708
J32.8
ICD-10 Finland
Other chronic sinusitis
55.9
145.2
173
32
J01DC02
ATC
cefuroxime; systemic
4.5
145.1
559
1357
R09
ICPC
Sinus symptom/complaint
3.9
141.5
649
1851
J01DB01
ATC
cefalexin; oral
2.6
140.8
4259
34656
R03BA01
ATC
beclometasone; inhalant
3.0
140.6
956
3678
UDC00
NOMESCO Finland
Ear microscopy
4.1
138.8
591
1576
R03BA08
ATC
ciclesonide; inhalant
3.7
137.6
663
1970
4222
FHL
Endonasal etmoidectomy
27.2
135.6
189
72
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
20.6
131.8
200
101
XG474
NOMESCO Finland
Exhalation nntrogen oxide
7.1
129.4
334
500
J01DA06
ATC
[U] cefuroxime; systemic
2.7
125.1
990
4155
J01FA06
ATC
roxithromycin; oral
2.1
124.5
2205
13766
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.4
124.3
490
1209
J01.4
ICD-10 Finland
Acute pansinusitis
20.5
123.8
188
95
DMB10
NOMESCO Finland
Radical maxillary antrotomy
34.4
121.9
160
48
DPA20
NOMESCO Finland
Trephine of frontal sinus
86.8
120.8
135
16
DHB40
NOMESCO Finland
Conchotomy
65.4
120.5
140
22
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.3
120.1
390
783
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.2
117.2
705
2466
R06AX22
ATC
ebastine; oral
2.5
115.7
1109
5162
XQ800
NOMESCO Finland
Prick test
3.5
114.5
592
1847
R03AC13
ATC
formoterol; inhalant
4.7
114.0
414
938
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
51.7
112.7
136
27
R03AC12
ATC
salmeterol; inhalant
5.2
110.3
362
734
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
109.6
2171
13940
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
7.6
108.3
266
369
R03BB04
ATC
tiotropium bromide; inhalant
3.3
108.3
605
1999
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
5.4
107.3
342
670
J32
ICD-10 Finland
Chronic sinusitis
24.1
105.5
152
65
R75
ICPC
Sinusitis acute/chronic
4.5
105.3
403
961
DHA10
NOMESCO Finland
Biopsy of cavity of nose
16.9
104.6
170
104
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
16.7
104.2
170
105
A02BC05
ATC
esomeprazole; systemic
1.9
100.8
2115
13739
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
9.2
100.3
217
245
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
134.0
98.4
105
8
J01MA14
ATC
moxifloxacin; systemic
3.1
98.0
586
2026
J01MA12
ATC
levofloxacin; systemic
2.3
95.0
1009
4886
J33
ICD-10 Finland
Nasal polyp
21.6
94.8
141
67
R03AK11
ATC
formoterol and fluticasone; inhalant
6.5
92.4
252
405
A02BC02
ATC
pantoprazole; systemic
1.9
90.9
3171
24256
R06AX13
ATC
loratadine; oral
2.3
90.5
943
4511
N02BE01
ATC
paracetamol; systemic, rectal
2.2
89.7
4235
36177
R03AC03
ATC
terbutaline; inhalant
2.4
87.8
834
3798
J33.1
ICD-10 Finland
Polypoid sinus degeneration
119.7
87.2
94
8
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.0
85.5
201
260
J01DA01
ATC
[U] cefalexin; systemic
1.8
84.9
3154
24341
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
84.3
2252
15589
R03DA04
ATC
theophylline; systemic, rectal
4.5
83.7
316
740
SPAT1263
SPAT
Sampling
1.8
83.7
2124
14441
WX110
NOMESCO Finland
Local anesthesy
1.8
83.2
3485
27884
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
83.0
2377
16800
J02AC01
ATC
fluconazole; systemic
1.8
77.4
2026
13801
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
77.4
1932
12960
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
7.3
76.5
191
271
J46
ICD-10 Finland
Status asthmaticus
5.4
76.4
240
460
J01
ICD-10 Finland
Acute sinusitis
3.7
75.6
359
1034
J32.3
ICD-10 Finland
Chronic sphenoidal sinusitis
46.3
74.2
91
20
R06AX26
ATC
fexofenadine; oral
3.0
74.1
466
1654
WX002
NOMESCO Finland
Sedation and analgesia
2.1
73.9
998
5320
4224
FHL
Endonasal anthrostomy
10.1
72.1
147
149
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
72.1
910
4706
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
3.4
71.1
370
1145
J01MA02
ATC
ciprofloxacin; systemic
1.8
70.5
1851
12510
J30.3
ICD-10 Finland
Other allergic rhinitis
4.1
67.6
277
700
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
67.0
1100
6305
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.3
66.2
678
3170
DPB00
NOMESCO Finland
Partial excision of frontal sinus
120.0
66.0
71
6
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
7.5
65.0
159
219
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
64.0
326
991
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
63.1
1735
11781
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.5
63.0
544
2327
R03DC01
ATC
zafirlukast; oral
7.1
63.0
160
233
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
61.9
280
772
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
61.6
361
1213
XX3DW
NOMESCO Finland
Time consuming IT work
2.4
60.9
553
2426
J01FF01
ATC
clindamycin; systemic
1.8
60.1
1366
8714
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
59.9
314
975
J45.8
ICD-10 Finland
Mixed asthma
4.5
59.3
219
500
H65.2
ICD-10 Finland
Chronic serous otitis media
9.6
59.3
124
132
J30.0
ICD-10 Finland
Vasomotor rhinitis
4.8
56.4
195
416
4226
FHL
Posterior radical surgery and possible etmoidectomy
11.6
56.1
106
93
N02AX02
ATC
tramadol; systemic, rectal
1.6
55.8
1989
14391
49300
ICD-8 Finland
Asthma, bronchiale
5.1
55.8
184
373
R05
ICD-10 Finland
Cough
1.9
55.2
931
5338
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.9
55.0
369
1357
J01DA08
ATC
[U] cefaclor; oral
2.2
54.4
611
2964
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
54.0
1357
8872
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
53.3
1046
6317
DM1CI
NOMESCO Finland
Very extensive cone beam CT of paranasal sinus
24.1
53.2
76
32
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.2
52.0
205
499
R01BA01
ATC
phenylpropanolamine; oral
2.9
51.8
339
1227
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
19.1
51.4
79
42
ZXE00
NOMESCO Finland
One hour or less
1.6
51.2
1851
13355
ZXC60
NOMESCO Finland
Application of heat
5.3
50.4
160
311
R51.80
ICD-10 Finland
Headache
2.0
50.3
750
4090
R06.0
ICD-10 Finland
Dyspnoea
1.8
50.1
1087
6765
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.7
48.9
350
1338
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
3.7
48.7
222
616
A02BC03
ATC
lansoprazole; oral
1.7
48.0
1343
9001
4732A
ICD-9 Finland
Chronic sinusitis, Ethmoidal
40.5
47.9
60
15
C01CA24
ATC
epinephrine; parenteral
2.6
47.6
367
1464
J47
ICD-10 Finland
Bronchiectasis
6.0
47.4
135
230
R02
ICPC
Shortness of breath/dyspnoea
2.1
47.3
573
2866
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
47.3
1648
11711
DHB10
NOMESCO Finland
Excision of lesion of internal nose
19.2
45.7
70
37
WX402
NOMESCO Finland
General anaesthesia
1.8
45.5
837
4912
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
45.3
1886
13968
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
44.9
1746
12711
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
8.2
44.7
102
127
ZXD20
NOMESCO Finland
Day surgery
2.0
44.5
657
3557
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
6.5
44.0
118
186
R01AD
ATC
Corticosteroids
6.1
43.0
120
200
ZXC99
NOMESCO Finland
Other special technic in surgery
33.3
42.9
56
17
M03BX02
ATC
tizanidine; oral
1.5
42.7
3022
25135
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.7
42.3
1202
8041
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
41.4
1702
12494
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
41.0
1086
7112
SPAT1310
SPAT
Counselling related to known health issue
1.6
40.9
1438
10152
50503
ICD-8 Finland
Nasal polyp, Ethmoidalis
33.5
40.7
53
16
R74
ICPC
Upper respiratory infection acute
1.6
40.2
1354
9445
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
39.4
320
1312
R01AX03
ATC
ipratropium bromide; nasal
4.5
39.1
144
329
G47.3
ICD-10 Finland
Sleep apnoea
1.7
38.7
1041
6829
DNB00
NOMESCO Finland
External ethmoidectomy
+∞
38.6
37
*
A02BA02
ATC
ranitidine; systemic
1.7
38.4
839
5178
R06.2
ICD-10 Finland
Wheezing
2.9
37.7
245
882
M01AH05
ATC
etoricoxib; oral
1.5
37.6
2813
23347
R07
ICPC
Sneezing/nasal congestion
2.4
37.1
339
1481
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
36.7
1890
14483
H66.9
ICD-10 Finland
Otitis media, unspecified
2.6
36.4
284
1140
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
36.3
890
5675
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
35.9
933
6044
DKW40
NOMESCO Finland
Ligature of artery of internal nose
35.7
35.9
46
13
M01AE02
ATC
naproxen; oral, rectal
1.5
35.9
2615
21494
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
35.7
1228
8563
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
8.0
35.6
82
104
DMW00
NOMESCO Finland
Intubation of maxillary antrum
22.9
34.8
50
22
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
34.7
1010
6742
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
34.2
1204
8427
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
33.9
1314
9406
J37.0
ICD-10 Finland
Chronic laryngitis
3.1
33.7
189
616
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
33.6
570
3230
E0000UV
ATC
NA
1.5
33.5
1734
13222
SPAT1153
SPAT
Removal of sutures
1.5
33.5
1385
10061
J02AC02
ATC
itraconazole; systemic
1.7
33.5
844
5412
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
33.4
335
1528
D07AC01
ATC
betamethasone; topical
1.5
33.4
1504
11132
A07AA02
ATC
nystatin; oral
2.4
33.4
292
1246
A02BC01
ATC
omeprazole; systemic
1.6
33.1
1188
8347
N03AX16
ATC
pregabalin; oral
1.6
32.9
1042
7097
DNW99
NOMESCO Finland
Other operation on ethmoidal sinus and bone
74.7
32.9
37
5
DFF00
NOMESCO Finland
Pure tone audiometry
2.1
32.2
401
2017
D72.1
ICD-10 Finland
Eosinophilia
11.9
32.0
59
50
A02BC04
ATC
rabeprazole; oral
2.0
32.0
415
2124
P01AB01
ATC
metronidazole; oral, rectal
1.5
31.8
1770
13667
297
Kela drug reimbursment
NA
47.8
31.5
38
8
3028
Kela drug reimbursment
Mepolizumab
47.8
31.5
38
8
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
31.5
572
3311
SPAT1036
SPAT
Maxillary puncture
18.6
31.3
48
26
R03BC03
ATC
nedocromil; inhalant
2.2
31.0
344
1646
J20
ICD-10 Finland
Acute bronchitis
2.0
30.6
429
2260
SPAT1312
SPAT
General health counselling
1.5
29.8
1374
10169
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
29.7
995
6849
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
9.8
29.5
60
62
R08
ICPC
Nose symptom/complaint other
3.0
29.3
180
624
R06.5
ICD-10 Finland
Mouth breathing
1.9
28.7
434
2353
H65.0
ICD-10 Finland
Acute serous otitis media
4.6
28.5
100
219
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
28.0
1285
9477
R03DX09
ATC
mepolizumab; parenteral
42.7
27.7
34
8
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
27.0
2220
18256
WZC30
NOMESCO Finland
Teaching
1.7
27.0
579
3526
R01AC01
ATC
cromoglicic acid; nasal
2.5
26.5
211
856
H02AB09
ATC
hydrocortisone; systemic
3.5
26.5
128
375
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
26.5
3285
28958
M25.5
ICD-10 Finland
Pain in joint
1.5
26.4
1248
9239
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
4.5
26.3
94
210
N03AX12
ATC
gabapentin; oral
1.7
26.3
672
4297
ZXB87
NOMESCO Finland
Balloon dilation, paranasal sinuses
33.2
25.5
33
10
SPAT1058
SPAT
PEF monitoring instruction
2.0
25.4
361
1911
A01AB09
ATC
miconazole; local oral
1.9
25.4
370
1974
SPAT1260
SPAT
Consultation of another employee
1.6
25.3
744
4938
ZFX00
NOMESCO Finland
Use of balloon dilatation
22.6
25.2
36
16
4239
FHL
Other measure in this category
9.1
25.1
53
59
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
20.7
25.1
37
18
J01MA01
ATC
ofloxacin; systemic
2.0
25.1
360
1909
EMB10
NOMESCO Finland
Tonsillectomy
2.1
25.1
283
1363
Z01.2
ICD-10 Finland
Dental examination
1.4
25.0
1840
14773
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
25.0
420
2360
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.8
25.0
107
284
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
24.5
2537
21544
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
24.5
1203
8948
J01DC04
ATC
cefaclor; oral
4.2
24.4
94
227
C05AA08
ATC
fluocortolone; rectal, topical
1.6
24.3
617
3935
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
24.3
2954
25735
WX290
NOMESCO Finland
Other blockade of nerve
1.4
24.2
2050
16826
D82
ICPC
Teeth/gum disease
1.4
24.0
1548
12119
R05FB02
ATC
cough suppressants and expectorants
1.4
23.9
1546
12105
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
23.6
1721
13755
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
23.6
1182
8822
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
23.2
1726
13835
H01
ICPC
Ear pain/earache
1.8
23.1
443
2598
M01AB05
ATC
diclofenac; systemic, rectal
1.4
23.0
3067
26993
DMA10
NOMESCO Finland
Exploration of maxillary antrum
20.1
23.0
34
17
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
22.3
546
3443
SPAT1325
SPAT
Vaccination
1.4
22.3
1295
9918
UJF32
NOMESCO Finland
Coloscopy
1.5
22.2
1024
7501
DM1ZD
NOMESCO Finland
NA
+∞
21.9
21
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
21.8
2396
20377
AA1AD
NOMESCO Finland
CT of head and brain
1.5
21.8
901
6448
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
21.6
2257
19037
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
8.7
21.5
46
53
SPAT1254
SPAT
Administration of medicine
1.6
21.4
530
3354
M54.5
ICD-10 Finland
Low back pain
1.4
21.3
1409
11026
A98
ICPC
Health maint/preventive medicine
1.8
21.3
4715
45317
DM1BI
NOMESCO Finland
Extensive cone beam CT of paranasal sinus
20.8
21.2
31
15
50304
ICD-8 Finland
Chronic sinusitis, Ethmoidalis
20.8
21.2
31
15
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
21.2
906
6523
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
7.9
21.2
48
61
D07AC13
ATC
mometasone; topical
1.4
21.1
1230
9409
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
3.4
21.1
104
311
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
50.2
21.1
25
5
ZZR50
NOMESCO Finland
Mucoperiosteal flap
50.2
21.1
25
5
J01FA01
ATC
erythromycin; systemic
1.6
21.1
624
4132
R05
ICPC
Cough
1.5
21.1
907
6543
J01CA02
ATC
pivampicillin; oral
2.5
21.0
168
687
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.6
20.8
153
596
M01AC06
ATC
meloxicam; systemic, rectal
1.4
20.7
1546
12336
J35.0
ICD-10 Finland
Chronic tonsillitis
2.1
20.6
246
1216
DNB40
NOMESCO Finland
Sublabial rhinotomy
110.5
20.6
22
*
Z01.9
ICD-10 Finland
Special examination, unspecified
2.1
20.4
235
1145
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
20.3
667
4528
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
20.3
2629
22811
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
20.2
1937
16067
R04.0
ICD-10 Finland
Epistaxis
2.0
20.1
266
1368
A03FA02
ATC
cisapride; oral, rectal
1.9
20.1
289
1537
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
8.7
20.1
43
50
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
20.0
415
2494
J30
ICD-10 Finland
Vasomotor and allergic rhinitis
3.6
20.0
90
251
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
19.9
666
4538
SPAT1301
SPAT
No procedures
1.4
19.9
1261
9774
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
19.8
3175
28380
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
19.8
818
5844
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
29.0
19.6
26
9
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
19.5
974
7221
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
19.5
440
2710
G50.1
ICD-10 Finland
Atypical facial pain
3.4
19.5
97
293
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
4.1
19.3
76
189
TDA90
NOMESCO Finland
Removal wax from ear
4.8
19.2
64
135
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
19.1
817
5875
M79.6
ICD-10 Finland
Pain in limb
1.4
19.1
1456
11623
Z51.6
ICD-10 Finland
Desensitization to allergens
4.0
19.0
77
196
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.3
19.0
172
749
WX704
NOMESCO Finland
Intubation
1.9
18.9
308
1711
WX199
NOMESCO Finland
Other local analgesia
2.8
18.9
121
435
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
18.9
409
2487
R51.81
ICD-10 Finland
Facial pain NOS
2.9
18.8
115
401
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
18.6
1643
13407
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
18.6
1033
7805
DPB20
NOMESCO Finland
Obliteration of frontal sinus
190.6
18.5
19
*
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
7.1
18.5
45
64
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
18.4
236
1200
K02.1
ICD-10 Finland
Caries of dentine
1.3
18.4
2553
22233
DM1QA
SPAT
NA
2.9
18.3
116
412
L08
ICPC
Shoulder symptom/complaint
1.5
18.3
740
5252
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
18.2
442
2774
D07AD01
ATC
clobetasol; topical
1.5
18.2
642
4426
R4110
NOMESCO Finland
Physiotherapy
0.7
18.0
594
8269
WX320
NOMESCO Finland
Spinalanesthesy
1.4
18.0
870
6404
N06AX21
ATC
duloxetine; oral
1.6
18.0
455
2892
G04CA01
ATC
alfuzosin; oral
1.7
17.8
425
2659
L01
ICPC
Neck symptom/complaint
1.6
17.7
545
3637
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
13.7
17.7
30
22
DPB10
NOMESCO Finland
Partial excision of sphenoidal sinus
180.6
17.5
18
*
N05CF02
ATC
zolpidem; oral
1.5
17.5
734
5245
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
17.4
347
2057
A03
ICPC
Fever
1.5
17.4
658
4598
DM1AI
SPAT
NA
8.3
17.4
38
46
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
17.4
475
3077
J01.8
ICD-10 Finland
Other acute sinusitis
5.9
17.3
48
82
N06AA09
ATC
amitriptyline; systemic
1.7
17.3
386
2368
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
17.3
410
2559
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
4.1
17.3
67
165
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
17.2
1037
7931
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
17.2
231
1199
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
17.0
1139
8867
SPAT1255
SPAT
Intravenous administration of medicine
1.9
17.0
267
1465
J31.1
ICD-10 Finland
Chronic nasopharyngitis
5.0
16.9
54
109
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
7.0
16.8
41
59
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
16.7
201
996
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
6.5
16.7
43
67
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
16.6
611
4244
J01.3
ICD-10 Finland
Acute sphenoidal sinusitis
15.1
16.6
27
18
J00
ICD-10 Finland
Acute nasopharyngitis [common cold]
2.8
16.6
106
380
DC1AD
NOMESCO Finland
Temporalbone CT
4.1
16.6
65
162
DJB10
NOMESCO Finland
Excision of septum of nose
90.4
16.6
18
*
SPAT1211
SPAT
Application of soft bandage
1.7
16.5
348
2102
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
16.4
241
1290
M01AX17
ATC
nimesulide; oral
1.4
16.4
939
7113
L50.8
ICD-10 Finland
Other urticaria
2.9
16.4
98
339
DGW00
NOMESCO Finland
Dilatation of eustachian tube
9.5
16.4
33
35
R03DX10
ATC
benralizumab; systemic
40.2
16.3
20
5
S18
ICPC
Laceration/cut
1.3
16.2
1661
13784
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
16.2
290
1664
M79.1
ICD-10 Finland
Myalgia
1.5
16.2
532
3605
E000002
ATC
NA
1.6
16.1
454
2964
ZZC00
NOMESCO Finland
Graft of fascia
16.7
16.0
25
15
J01.2
ICD-10 Finland
Acute ethmoidal sinusitis
24.5
16.0
22
9
R01AC02
ATC
levocabastine; nasal
2.4
16.0
138
589
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
9.5
15.9
32
34
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
15.8
346
2110
R81
ICPC
Pneumonia
2.3
15.7
140
607
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
15.7
247
1357
AAE99
NOMESCO Finland
Other operation by cranial base approach
33.4
15.7
20
6
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.6
15.7
448
2935
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
15.6
357
2205
GD1AA
SPAT
NA
1.7
15.6
320
1916
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
3.3
15.5
78
239
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.8
15.5
286
1656
H05.0
ICD-10 Finland
Acute inflammation of orbit
22.1
15.5
22
10
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
15.5
327
1973
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
15.5
303
1790
T78.4
ICD-10 Finland
Allergy, unspecified
2.0
15.4
196
995
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.9
15.4
234
1270
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
4.5
15.2
53
118
WQ000
NOMESCO Finland
Hyposensibilisation
5.9
15.2
42
72
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
15.2
169
810
A03CA02
ATC
clidinium and psycholeptics; oral
1.9
15.2
219
1167
3027
Kela drug reimbursment
Benralizumab
28.7
15.2
20
7
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
15.1
1202
9590
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
15.1
590
4144
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
15.0
297
1756
4227
FHL
Forehead cavity drainage
11.8
15.0
27
23
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
15.0
329
2010
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
4.8
14.9
49
103
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
15.1
14.8
24
16
R01AC07
ATC
nedocromil; nasal
6.2
14.8
39
63
XQ820
NOMESCO Finland
Exposure to medicinal substance
7.9
14.8
33
42
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
14.8
696
5077
R06AX18
ATC
acrivastine; oral
2.4
14.7
130
561
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
14.7
415
2707
H92.0
ICD-10 Finland
Otalgia
1.9
14.7
207
1091
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.3
14.7
141
634
J01GB01
ATC
tobramycin; inhalant, parenteral
25.1
14.7
20
8
SPAT1097
SPAT
Recording of ECG
1.5
14.6
528
3648
SPAT1104
SPAT
Monitoring of emergency patient
1.8
14.6
260
1489
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
14.6
418
2735
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
14.5
441
2930
G44.2
ICD-10 Finland
Tension-type headache
1.5
14.5
532
3689
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
14.5
287
1701
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
5.2
14.5
44
85
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
14.3
775
5797
R42
ICD-10 Finland
Dizziness and giddiness
1.4
14.3
753
5606
251
Kela drug reimbursment
NA
27.2
14.3
19
7
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
14.2
609
4360
C09CA06
ATC
candesartan; oral
1.4
14.1
823
6242
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
14.0
1195
9614
WX400
NOMESCO Finland
Inhalation anesthesy
2.0
14.0
191
996
R78
ICPC
Acute bronchitis/bronchiolitis
2.6
14.0
103
405
J01AA04
ATC
lymecycline; systemic
1.5
14.0
537
3762
H03AA01
ATC
levothyroxine sodium; systemic
1.4
14.0
857
6551
N01
ICPC
Headache
1.6
14.0
370
2377
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
13.9
1349
11049
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
15.8
13.9
22
14
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
13.9
419
2778
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.7
13.8
96
366
L50.9
ICD-10 Finland
Urticaria, unspecified
2.1
13.8
150
716
K30
ICD-10 Finland
Functional dyspepsia
1.6
13.8
400
2629
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
13.7
349
2218
Z00.0
ICD-10 Finland
General medical examination
1.4
13.7
703
5205
SPAT1262
SPAT
Handing over of treatment supplies
1.4
13.7
682
5025
GD1AD
NOMESCO Finland
Thorax CT examination
2.0
13.7
172
871
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
13.7
468
3194
N06AX11
ATC
mirtazapine; oral
1.3
13.7
1268
10324
UKC02
NOMESCO Finland
Cystoscopy
1.5
13.6
549
3882
TGC00
NOMESCO Finland
Bronchial lavation
2.5
13.6
108
444
S02CA02
ATC
flumetasone and antiinfectives; otic
1.8
13.6
217
1199
50300
ICD-8 Finland
Chronic sinusitis, Maxillaris cum empyemate
5.7
13.5
38
67
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
4.6
13.5
46
101
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
13.5
1739
14781
J01X
ATC
OTHER ANTIBACTERIALS
4.8
13.4
44
93
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
13.4
503
3507
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.6
13.4
329
2072
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
13.3
410
2730
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
21.2
13.3
19
9
J05AB01
ATC
aciclovir; systemic
1.4
13.3
834
6395
R50.9
ICD-10 Finland
Fever, unspecified
1.5
13.2
523
3682
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
13.2
509
3566
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
13.1
593
4286
WX723
NOMESCO Finland
CPAP therapy
2.0
13.1
163
822
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
4.2
13.0
48
114
WX720
NOMESCO Finland
Own respiration
2.0
13.0
163
825
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
13.0
1064
8495
4618A
ICD-9 Finland
Acute sinusitis, Other acute sinusitis
8.3
13.0
28
34
DKW99
NOMESCO Finland
Other procedures for control of epistaxis
8.7
13.0
27
31
4738X
ICD-9 Finland
Chronic sinusitis, Other chronic sinusitis
28.4
12.9
17
6
R06AE08
ATC
NA
3.7
12.9
55
149
R13
ICD-10 Finland
Dysphagia
1.8
12.9
230
1322
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.1
12.8
148
726
A01AB04
ATC
amphotericin B; local oral
2.0
12.8
167
859
R01AD04
ATC
flunisolide; nasal
4.5
12.8
44
98
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
12.8
771
5868
L50.3
ICD-10 Finland
Dermatographic urticaria
2.8
12.8
80
287
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
12.8
729
5498
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
12.7
372
2449
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
14.0
12.7
21
15
C08DA01
ATC
verapamil; systemic
2.1
12.7
144
698
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.9
12.6
74
255
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
12.6
249
1477
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.7
12.5
255
1523
XKD00
NOMESCO Finland
Uroflowmetry
1.5
12.5
521
3705
-44
ICPC
Preventive immunization/medic
1.6
12.5
291
1810
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
20.1
12.4
18
9
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.6
12.3
351
2295
E000001
ATC
NA
1.4
12.3
791
6079
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.9
12.3
73
254
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
12.3
256
1542
D01BA02
ATC
terbinafine; oral; topical
1.3
12.3
983
7819
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
12.2
663
4953
M02AA07
ATC
piroxicam; topical
1.3
12.1
1391
11608
XG405
NOMESCO Finland
Education on PEF monitoring
3.0
12.1
70
238
395
Kela drug reimbursment
Dupilumab
12.4
12.1
21
17
XQ802
NOMESCO Finland
Epicutan test
1.9
12.0
172
917
R05DA01
ATC
ethylmorphine; oral
1.6
12.0
306
1946
1470
FHL
Rectoscopy
4.5
12.0
41
91
R51
ICD-10 Finland
Headache
1.8
12.0
209
1190
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.3
12.0
114
513
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.4
11.9
97
405
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.1
11.9
136
664
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
6.8
11.9
29
43
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.8
11.9
214
1234
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.4
11.9
717
5454
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
11.8
1498
12653
E000007
ATC
NA
1.8
11.8
215
1241
L03
ICPC
Low back symptom/complaint
1.3
11.8
915
7238
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
5.4
11.7
34
63
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
11.7
633
4722
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
11.7
371
2489
G04BD12
ATC
mirabegron; oral
1.6
11.7
324
2106
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
2.3
11.6
104
455
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.4
11.6
559
4085
R52.2
ICD-10 Finland
Other chronic pain
2.1
11.6
136
670
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.0
11.5
145
738
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.2
11.5
112
511
DJW99
NOMESCO Finland
Other operation on septum of nose
11.1
11.5
21
19
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
11.5
276
1728
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
11.5
317
2059
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.3
11.4
100
433
D11AH05
ATC
dupilumab; topical
13.6
11.4
19
14
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
11.4
413
2854
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
11.3
158
835
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
6.3
11.3
29
46
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
4.6
11.3
38
83
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.5
11.3
445
3126
J31
ICD-10 Finland
Chronic rhinitis, nasopharyngitis and pharyngitis
3.6
11.3
49
136
K08.80
ICD-10 Finland
Toothache NOS
1.6
11.3
312
2028
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
11.2
267
1667
A06AC51
ATC
ispaghula, combinations; systemic
1.8
11.2
188
1059
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
11.2
229
1373
R29
ICPC
Respiratory symptom/complaint other
1.7
11.2
232
1394
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.6
11.2
262
1632
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.4
11.2
475
3392
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.0
11.2
137
688
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.8
11.2
200
1150
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
11.1
113
2055
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
2.5
11.1
82
325
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
4.3
11.1
40
94
L90
ICPC
Osteoarthrosis of knee
1.7
11.1
207
1208
R53
ICD-10 Finland
Malaise and fatigue
1.4
11.1
710
5448
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
3.3
11.0
53
160
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
11.0
273
1726
J01DB05
ATC
cefadroxil; oral
1.8
10.9
184
1039
DHB30
NOMESCO Finland
Polypectomy of choana through maxillary antrum
43.4
10.9
13
*
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
6.9
10.8
26
38
M02AA10
ATC
ketoprofen; topical
1.4
10.8
584
4360
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.9
10.8
163
887
R43.0
ICD-10 Finland
Anosmia
3.9
10.7
42
107
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.8
10.7
176
984
1210
FHL
Anthroscopy
6.1
10.7
28
46
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.0
10.7
125
618
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
60.1
10.6
12
*
N06AX16
ATC
venlafaxine; oral
1.4
10.6
554
4109
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.8
10.6
186
1064
R06AX12
ATC
terfenadine; oral
1.8
10.6
188
1081
4212
FHL
Maxillapremmaxilla opening septum resection and reconstruction
4.6
10.6
35
76
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
2.1
10.6
119
578
K04.0
ICD-10 Finland
Pulpitis
1.5
10.5
404
2826
G01AF05
ATC
econazole; vaginal
1.6
10.5
305
2008
K07.60
ICD-10 Finland
Snapping jaw
1.7
10.5
194
1131
ZZF00
NOMESCO Finland
Graft of adipose tissue
3.6
10.4
46
130
M79.7
ICD-10 Finland
Fibromyalgia
2.0
10.4
128
647
SPAT1059
SPAT
Spirometry at the office
1.8
10.4
188
1084
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
4.4
10.4
36
82
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
10.4
475
3440
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
10.4
1435
12208
120
Kela drug reimbursment
Hypogammaglobulinaemia
7.7
10.4
23
30
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
8.2
10.3
22
27
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
10.3
233
1436
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
10.2
112
540
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
10.2
212
1277
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
10.2
177
1012
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
10.2
659
5066
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
10.1
420
2983
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
10.1
712
5538
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.5
10.1
336
2278
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.5
10.1
358
2464
L15
ICPC
Knee symptom/complaint
1.3
10.1
746
5851
SPAT1043
SPAT
Audiometry
1.5
10.1
321
2159
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
6.9
10.1
24
35
R03BB01
ATC
ipratropium bromide; inhalant
2.1
10.0
113
551
H25.8
ICD-10 Finland
Other senile cataract
1.6
9.9
260
1666
R03AC04
ATC
fenoterol; inhalant
5.8
9.9
27
47
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.8
9.8
159
885
H71
ICPC
Acute otitis media/myringitis
2.8
9.8
59
209
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.4
9.8
30
829
M54.2
ICD-10 Finland
Cervicalgia
1.6
9.8
269
1747
WX780
NOMESCO Finland
Remote monitoring CPAP
1.8
9.7
167
949
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
55.1
9.6
11
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
9.6
402
2859
R49.08
ICD-10 Finland
Other specified dysphonia
2.3
9.6
85
373
X58
ICD-10 Finland
Exposure to other specified factors
1.4
9.6
526
3931
G01AF04
ATC
miconazole; vaginal
1.7
9.6
182
1069
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
2.9
9.6
55
188
R35
ICD-10 Finland
Polyuria
1.7
9.5
208
1273
M77.1
ICD-10 Finland
Lateral epicondylitis
1.5
9.5
301
2019
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.6
9.5
222
1381
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.2
9.5
92
420
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
9.5
9
453
R32
ICD-10 Finland
Unspecified urinary incontinence
2.2
9.5
89
400
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
9.4
1088
9039
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.2
9.4
94
435
J01XB01
ATC
colistin; inhalant, parenteral
100.2
9.4
10
*
CAC20
NOMESCO Finland
Lateral decompression of orbit
100.2
9.4
10
*
A02BA04
ATC
nizatidine; systemic
1.6
9.4
262
1706
CS494
NOMESCO Finland
Other visual field testing
2.3
9.4
81
351
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
9.4
1126
9399
DCW00
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
+∞
9.4
9
*
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
2.2
9.3
91
417
L17
ICPC
Foot/toe symptom/complaint
1.3
9.3
900
7315
D11
ICPC
Diarrhoea
1.4
9.3
416
2999
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.0
9.3
110
548
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.9
9.3
129
682
N02AA05
ATC
oxycodone; systemic
1.4
9.3
444
3239
D01AE16
ATC
amorolfine; topical
1.4
9.3
399
2853
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.6
9.3
248
1599
M23.8
ICD-10 Finland
Other internal derangements of knee
1.8
9.3
147
818
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.6
9.3
256
1667
XKC03
NOMESCO Finland
Water cystometry
2.0
9.2
108
537
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.7
9.2
186
1112
LEG12
NOMESCO Finland
Transobturatoric tape
2.6
9.2
66
257
N05AH02
ATC
clozapine; systemic
0.2
9.2
9
445
J01EA01
ATC
trimethoprim; systemic
1.3
9.2
854
6907
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.2
9.2
90
415
Z3231
NOMESCO Finland
Registered nurse
0.8
9.2
668
8333
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.0
9.1
115
586
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
9.1
280
1865
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
9.1
436
3184
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.2
9.1
90
417
4719X
ICD-9 Finland
Nasal polyps, Unspecified nasal polyp
11.5
9.0
16
14
EMB30
NOMESCO Finland
Adenotomy
2.4
9.0
73
307
D02AE01
ATC
carbamide; topical
1.6
9.0
247
1603
DFF59
NOMESCO Finland
Other assessment of balance
3.1
9.0
48
158
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.4
9.0
70
289
R03DA05
ATC
aminophylline; systemic, rectal
4.0
9.0
34
85
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
2.2
9.0
86
392
50509
ICD-8 Finland
Nasal polyp, Unspecified
24.0
8.9
12
5
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.8
8.9
54
194
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.7
8.9
24
42
J01CA08
ATC
pivmecillinam; oral
1.2
8.9
1418
12210
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
1.7
8.8
196
1206
-54
ICPC
Repair/fix-suture/cast/prosth device
2.1
8.8
95
456
M67.4
ICD-10 Finland
Ganglion
1.6
8.8
239
1549
L04
ICPC
Chest symptom/complaint
1.7
8.8
189
1153
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
8.8
390
2807
N05BA04
ATC
oxazepam; oral
1.3
8.8
912
7475
L13
ICPC
Hip symptom/complaint
1.4
8.8
496
3725
G43.9
ICD-10 Finland
Migraine, unspecified
1.6
8.8
218
1382
R07.0
ICD-10 Finland
Pain in throat
1.6
8.8
226
1447
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.4
8.8
41
123
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
8.8
288
1953
J34.0
ICD-10 Finland
Abscess, furuncle and carbuncle of nose
6.3
8.8
22
35
OAB43
SPAT
NA
1.3
8.7
689
5447
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
8.7
412
3001
FN1AD
NOMESCO Finland
CT of coronary arteries
2.6
8.7
60
231
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
8.7
217
1374
SPAT1238
SPAT
Brief therapy
2.3
8.7
77
340
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.3
8.7
41
124
304
Kela drug reimbursment
Dornase alfa
50.1
8.7
10
*
DPW00
NOMESCO Finland
Intubation of frontal sinus
50.1
8.7
10
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
50.1
8.7
10
*
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.1
8.7
45
146
EB1MA
NOMESCO Finland
Cephalometry with X-ray
2.2
8.7
81
365
DAX08
NOMESCO Finland
Fitting of hearing aid
1.9
8.6
124
667
R00.2
ICD-10 Finland
Palpitations
1.5
8.6
252
1662
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
2.8
8.6
52
186
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.3
8.6
78
347
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
4.2
8.5
31
75
DJW00
NOMESCO Finland
Removal of local lesion of nasal septum
16.3
8.5
13
8
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
8.5
1288
11023
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
3.0
8.5
47
160
50499
ICD-8 Finland
Deflected nasal septum
2.5
8.4
62
248
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
8.4
247
1632
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.5
8.4
317
2210
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
4.1
8.4
31
76
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
8.4
345
2446
M01AH02
ATC
rofecoxib; oral
1.4
8.4
430
3177
SBB10
NOMESCO Finland
Teeth copy
1.6
8.4
217
1390
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
8.4
610
4764
4211
FHL
Transeptal septal resection and reconstruction
2.9
8.3
48
165
N02CC03
ATC
zolmitriptan; nasal, oral
1.6
8.3
216
1383
R83
ICPC
Respiratory infection other
1.3
8.3
972
8080
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
8.3
13
494
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
8.2
159
940
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.0
8.2
31
78
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.0
8.2
99
499
N05CF01
ATC
zopiclone; oral
1.2
8.1
1155
9806
V01AA02
ATC
grass pollen; systemic
6.0
8.1
21
35
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
8.1
142
817
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.7
8.1
165
994
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.5
8.1
268
1822
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.8
8.1
123
676
4742A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Adenoid vegetations
2.3
8.0
71
311
R03BB07
ATC
umeclidinium bromide; inhalant
3.5
8.0
35
100
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
22.0
8.0
11
5
L16
ICPC
Ankle symptom/complaint
1.4
8.0
346
2480
Z37.0
ICD-10 Finland
Single live birth
0.6
8.0
120
1968
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.8
8.0
47
166
DKW10
NOMESCO Finland
Packing of anterior cavity of nose
5.9
8.0
21
36
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.9
8.0
110
582
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
2.0
7.9
91
452
G04CA02
ATC
tamsulosin; oral
1.3
7.9
681
5445
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
7.9
4215
40563
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.7
7.9
161
969
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
7.9
294
2049
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.2
7.8
78
363
4225
FHL
Exploratory buccal opening, includes polyps and cyst removal
5.7
7.8
21
37
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
8.4
7.8
16
19
J35.1
ICD-10 Finland
Hypertrophy of tonsils
2.4
7.8
61
253
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
9.4
7.8
15
16
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
7.8
964
8061
ZXC10
NOMESCO Finland
Use of laser
2.0
7.7
89
440
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
2.8
7.7
46
164
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
45.0
7.7
9
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.5
7.6
290
2027
H53.2
ICD-10 Finland
Diplopia
1.9
7.6
105
557
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
7.6
289
2022
B01AF01
ATC
rivaroxaban; oral
1.4
7.6
366
2681
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
7.5
595
4704
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
5.4
7.5
21
39
J42
ICD-10 Finland
Unspecified chronic bronchitis
2.9
7.5
43
148
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.4
7.5
62
265
-50
ICPC
Medication/prescr/renewal
1.7
7.5
142
840
-1
NOMESCO Finland
NA
1.2
7.5
1338
11622
R03CC02
ATC
salbutamol; systemic
1.6
7.5
175
1094
N81.6
ICD-10 Finland
Rectocele
1.6
7.4
194
1246
WX702
NOMESCO Finland
Supraglottic ventilation device
1.6
7.4
197
1272
DH_2
NOMESCO Finland
Endoscopy of nose
80.2
7.4
8
*
N07CA01
ATC
betahistine; oral
1.5
7.4
232
1558
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.7
7.4
141
832
SPAT1053
SPAT
Memory test
1.4
7.4
358
2622
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
7.4
236
1591
TDC10
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
13.4
7.4
12
9
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
2.1
7.3
82
403
O80.8
ICD-10 Finland
Other single spontaneous delivery
1.7
7.3
128
740
46104
ICD-8 Finland
Acute sinusitis, Pansinuitis
6.8
7.3
17
25
WW200
SPAT
NA
0.7
7.3
214
3056
R12
ICD-10 Finland
Heartburn
1.5
7.2
236
1599
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.5
7.2
252
1732
J04.0
ICD-10 Finland
Acute laryngitis
1.8
7.2
112
619
S01EE05
ATC
tafluprost; ophthalmic
1.9
7.2
96
502
J38.7
ICD-10 Finland
Other diseases of larynx
3.9
7.2
28
73
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
7.2
439
3339
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
2.5
7.2
51
203
N05BA12
ATC
alprazolam; oral
1.4
7.1
373
2765
F60.5
ICD-10 Finland
Anankastic personality disorder
2.7
7.1
46
172
C10AC01
ATC
colestyramine; oral
1.9
7.1
95
498
J35.2
ICD-10 Finland
Hypertrophy of adenoids
2.4
7.1
57
241
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.6
7.1
181
1157
WX204
NOMESCO Finland
Axillary plexus blockaced
1.8
7.1
115
648
-31
ICPC
Medical examin/health eval partial
1.5
7.1
230
1559
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
7.9
7.1
15
19
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.5
7.1
31
90
M95.0
ICD-10 Finland
Acquired deformity of nose
3.5
7.1
31
90
M48.0
ICD-10 Finland
Spinal stenosis
1.4
7.1
364
2694
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.6
7.0
193
1260
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.1
7.0
35
112
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
2.2
7.0
67
307
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
2.0
7.0
82
412
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.4
7.0
364
2700
M76.0
ICD-10 Finland
Gluteal tendinitis
2.2
7.0
67
309
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
6.9
160
998
H05.2
ICD-10 Finland
Exophthalmic conditions
6.3
6.9
17
27
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
2.1
6.9
76
369
NG2AA
NOMESCO Finland
Patella X-ray examination
1.9
6.9
90
471
YHMAS
NOMESCO Finland
NA
3.0
6.9
36
119
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.0
6.9
77
380
JG1JB
NOMESCO Finland
Defekography with X-ray
3.2
6.9
34
108
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
6.9
185
1198
344
Kela drug reimbursment
Omalizumab
7.5
6.9
15
20
R21
ICPC
Throat symptom/complaint
1.3
6.9
726
5951
G01AF02
ATC
clotrimazole; vaginal
1.7
6.9
131
776
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.3
6.9
416
3164
R03BC01
ATC
cromoglicic acid; inhalant
2.3
6.8
59
260
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
6.8
1495
13206
DFF15
NOMESCO Finland
Speech audiometry
1.7
6.8
132
783
S02.50
ICD-10 Finland
Fracture of tooth, closed
2.1
6.8
71
339
4451
FHL
Guitar cutting
1.8
6.8
103
567
ZXC35
NOMESCO Finland
Use of radio waves
4.8
6.8
21
44
M01AC01
ATC
piroxicam; systemic, rectal
1.3
6.8
476
3694
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
6.8
410
3115
R05CB02
ATC
bromhexine; systemic
2.6
6.8
46
179
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.6
6.8
173
1107
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
6.8
2030
18414
M31.3
ICD-10 Finland
Wegener granulomatosis
5.0
6.8
20
40
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.8
6.8
119
686
N41.1
ICD-10 Finland
Chronic prostatitis
2.0
6.8
84
431
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.2
6.7
32
99
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.6
6.7
28
78
N06AA10
ATC
nortriptyline; systemic
2.0
6.7
82
418
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
1.8
6.7
102
560
DMW99
NOMESCO Finland
Other operation on maxillary antrum
16.7
6.7
10
6
H10
ICD-10 Finland
Conjunctivitis
1.5
6.7
215
1454
N04BC05
ATC
pramipexole; oral
1.5
6.7
229
1570
N03AX11
ATC
topiramate; oral
1.8
6.6
98
537
GD1UN
NOMESCO Finland
Lung circulation SPECT
3.8
6.6
26
69
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.5
6.6
236
1631
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.6
6.6
173
1115
C05AA01
ATC
hydrocortisone; rectal, topical
1.6
6.6
176
1138
B02AA02
ATC
tranexamic acid; systemic
1.3
6.6
525
4148
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.8
6.6
101
557
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
2.6
6.6
45
176
K51.5
ICD-10 Finland
Left sided colitis
1.8
6.6
107
604
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.3
6.6
422
3235
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.6
6.6
165
1054
H92.1
ICD-10 Finland
Otorrhoea
7.8
6.6
14
18
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
6.6
324
2380
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
1.7
6.6
137
834
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.2
6.6
64
296
SPAT1377
SPAT
Polysomnography
1.7
6.6
123
726
J05AH02
ATC
oseltamivir; oral
3.0
6.6
35
118
SPAT1283
SPAT
Restricted health certificate
1.3
6.6
677
5532
N06AB10
ATC
escitalopram; oral
1.2
6.6
751
6213
H57.1
ICD-10 Finland
Ocular pain
1.8
6.6
110
627
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
2.2
6.5
59
265
M65.3
ICD-10 Finland
Trigger finger
1.6
6.5
148
920
L20.0
ICD-10 Finland
Besnier prurigo
1.5
6.5
229
1578
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.7
6.5
121
712
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.7
6.5
40
147
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.6
6.5
172
1113
C07AA05
ATC
propranolol; systemic
1.2
6.5
722
5949
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.0
6.5
76
383
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
6.5
370
2788
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
6.5
406
3103
SPAT1281
SPAT
Other administrative function
1.4
6.5
276
1974
J35.8
ICD-10 Finland
Other chronic diseases of tonsils and adenoids
3.5
6.5
28
81
DHB45
NOMESCO Finland
Turbinate reduction
6.2
6.5
16
26
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.5
6.4
191
1270
H70.1
ICD-10 Finland
Chronic mastoiditis
5.3
6.4
18
34
FM1TQ
NOMESCO Finland
Heart perfusion SPECT with low dose CT at rest and with exercise
5.3
6.4
18
34
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
6.4
658
5372
DLD00
NOMESCO Finland
Reconstruction of cartilage of nose
5.7
6.4
17
30
S02.51
ICD-10 Finland
Fracture of tooth, open
1.4
6.4
365
2744
Z04.3
ICD-10 Finland
Examination and observation following other accident
1.9
6.4
82
427
H66
ICD-10 Finland
Suppurative and unspecified otitis media
2.0
6.4
75
376
A07EC02
ATC
mesalazine; oral, rectal
1.5
6.4
207
1400
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.0
6.4
77
389
H25.0
ICD-10 Finland
Senile incipient cataract
1.6
6.4
158
1003
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
2.2
6.4
63
293
TDP05
NOMESCO Finland
Puncture of frontal sinus
69.9
6.4
7
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.5
6.4
198
1331
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
6.4
522
4142
D07AA02
ATC
hydrocortisone; topical
1.3
6.4
475
3722
N05AX12
ATC
aripiprazole; systemic
0.5
6.4
46
917
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
6.4
890
7524
XX9TE
NOMESCO Finland
Compementary ultrasound examination
3.2
6.4
30
93
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.1
6.4
32
104
E66.01
ICD-10 Finland
Obesity due to excess calories
1.4
6.4
284
2053
Z3232
NOMESCO Finland
Midwife
0.6
6.3
114
1795
R44
ICPC
Respiratory, Preventive immunization/medic
2.3
6.3
52
224
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.4
6.3
324
2398
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
3.1
6.3
31
99
R03
ICPC
Wheezing
2.6
6.3
42
162
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
2.8
6.3
37
132
P72
ICPC
Schizophrenia
0.3
6.3
11
390
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.3
6.3
373
2825
K03.66
ICD-10 Finland
Tooth plaque
1.5
6.3
214
1467
N05AX08
ATC
risperidone; systemic
0.6
6.3
102
1639
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.3
6.3
52
226
JK3AN
NOMESCO Finland
Biliary tract isotope imaging
+∞
6.2
6
*
SFC00
NOMESCO Finland
Pillar of fillings material
1.8
6.2
100
564
S01GX02
ATC
levocabastine; ophthalmic
1.5
6.2
222
1535
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
6.2
173
1132
HAHOM
NOMESCO Finland
NA
2.6
6.2
42
165
H93.1
ICD-10 Finland
Tinnitus
1.5
6.2
227
1581
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
6.2
456
3569
A01AB10
ATC
natamycin; local oral
1.8
6.2
92
508
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.4
6.1
245
1732
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
2.6
6.1
41
159
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
3.3
6.1
28
85
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
6.1
469
3689
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.4
6.1
309
2283
TDH60
NOMESCO Finland
Removal of foreign body of nose
7.7
6.1
13
17
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
6.1
232
1626
J39.8
ICD-10 Finland
Other specified diseases of upper respiratory tract
4.2
6.1
21
50
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
6.1
327
2438
NBG10
NOMESCO Finland
Acromioplastia
1.8
6.1
93
516
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
2.2
6.1
54
243
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.7
6.1
113
666
NB1CM
NOMESCO Finland
Shoulder and humerus extensive MRI examination with 3 Tesla magnet
4.6
6.1
19
41
H02
ICPC
Hearing complaint
1.4
6.1
332
2482
J01MA06
ATC
norfloxacin; oral
1.3
6.1
453
3552
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
8.6
6.0
12
14
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
6.0
305
2253
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.2
6.0
56
257
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.4
6.0
331
2480
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.2
6.0
954
8166
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
1157
2853
4.88
307.65
1.9
1.2
u/ml
276.5
205.4
1.21
1108
2648
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
277
296
9.80
234.76
1.5
1.3
u/ml
1.4
0.6
0.87
152
125
(3007853) Bacteria identified in Skin by Aerobe culture
1239
5132
2.83
202.12
2.3
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1245
6164
2.32
133.36
2.4
2.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
255
477
5.56
129.85
1.7
1.4
g/l
0.4
0.4
1.44
185
330
(3028192) IgG subclass 2 [Mass/volume] in Serum
255
477
5.56
129.85
1.7
1.4
g/l
3.0
2.9
0.35
183
332
(3027135) IgG subclass 1 [Mass/volume] in Serum
255
478
5.55
129.56
1.7
1.4
g/l
6.4
6.8
0.67
185
331
(4062490)
251
478
5.46
125.31
1.7
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2347
15091
1.97
124.48
6.4
6.0
—
—
—
0
0
(4010399)
750
3065
2.68
120.72
1.7
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
312
768
4.25
114.19
1.2
1.1
u/ml
0.7
1.8
2.99
107
179
(3013115) Eosinophils [#/volume] in Blood
3212
23443
1.90
111.54
6.6
6.2
e9/l
0.3
0.2
89.05
2928
20752
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
338
933
3.80
105.48
1.2
1.1
u/ml
0.5
1.5
2.53
188
347
(3002030) Lymphocytes/100 leukocytes in Blood
3023
21919
1.85
104.11
6.7
6.2
%
28.2
28.4
0.47
2829
20527
(3019069) Monocytes/100 leukocytes in Blood
2953
21269
1.85
103.79
7.0
6.4
%
8.2
8.5
7.11
2795
20024
(3006504) Eosinophils/100 leukocytes in Blood
2933
21145
1.84
102.11
6.7
6.1
%
4.0
2.8
74.95
2749
19789
(3018010) Neutrophils/100 leukocytes in Blood
2974
21604
1.83
100.25
6.4
6.0
%
56.0
56.9
4.50
2799
20310
(3013512) EKG study
1916
12175
1.88
99.49
3.8
3.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
308
830
3.87
99.41
1.2
1.1
u/ml
2.3
5.3
4.65
190
416
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1028
5265
2.17
98.15
4.3
4.3
%
32.2
31.8
0.54
744
3707
(3024980) IgG subclass 4 [Mass/volume] in Serum
293
770
3.96
97.95
1.9
1.6
g/l
1.0
0.8
1.33
215
586
(3023419) Bacteria identified in Sputum by Culture
231
506
4.72
97.91
4.5
2.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4138
33482
1.97
97.57
5.1
3.9
mm/h
10.9
11.2
0.88
3856
31247
(3022096) Basophils/100 leukocytes in Blood
2843
20482
1.81
97.41
6.7
6.2
%
0.7
0.7
7.46
2674
19193
(3014133) Dog dander IgE Ab [Units/volume] in Serum
270
679
4.13
95.86
1.2
1.0
u/ml
2.0
3.6
1.36
139
254
(3006315) Basophils [#/volume] in Blood
3064
22687
1.80
94.62
6.5
6.0
e9/l
0.0
0.0
19.78
2788
19718
(3023430) Cat dander IgE Ab [Units/volume] in Serum
254
623
4.23
93.22
1.1
1.0
u/ml
2.2
4.0
1.31
127
236
(3001604) Monocytes [#/volume] in Blood
3043
22605
1.78
91.72
6.5
6.0
e9/l
0.6
0.6
1.65
2780
19653
(3019198) Lymphocytes [#/volume] in Blood
3112
23292
1.78
91.17
6.5
6.0
e9/l
2.0
1.9
0.16
2858
20666
(3008401) Mugwort IgE Ab [Units/volume] in Serum
288
799
3.75
89.04
1.2
1.1
u/ml
0.8
1.1
0.34
155
317
(40768804) Tissue Pathology biopsy report
2584
18429
1.76
88.55
2.1
2.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
416
1479
2.96
86.09
1.8
1.6
titre
132.6
409.2
1.86
19
61
(3019225) pH of Specimen
816
4084
2.17
81.33
4.0
4.1
—
—
—
0
0
(3000492) Spirometry study
891
4635
2.10
80.26
1.7
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
719
3490
2.22
77.09
3.3
2.7
g/l
10.1
10.6
2.35
663
3194
(3028026) IgM [Mass/volume] in Serum or Plasma
598
2706
2.36
75.66
1.8
1.9
g/l
1.2
1.4
2.06
551
2492
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
121
187
6.59
74.73
1.1
1.1
u/ml
5.0
6.2
0.23
29
34
(3009445) Proteinase 3 Ab [Units/volume] in Serum
455
1841
2.61
73.23
1.7
1.5
u/ml
6.3
15.0
1.32
13
49
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
206
564
3.76
64.80
1.1
1.0
u/ml
0.3
0.3
0.06
71
117
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
259
825
3.25
64.49
1.3
1.2
titre
60.0
267.5
—
7
16
(3036481) Cortisol [Moles/volume] in Serum or Plasma
772
4182
1.99
60.93
2.6
2.2
nmol/l
324.8
370.6
6.86
722
3865
(3013650) Neutrophils [#/volume] in Blood by Automated count
3250
26077
1.61
60.88
8.3
9.3
e9/l
4.1
4.1
0.65
2967
22877
(40761536) Microorganisms panel - Urine sediment
713
3757
2.03
60.83
3.8
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2174
15959
1.60
58.52
3.7
3.3
ng/l
29.9
78.5
0.91
1358
10093
(3032080) INR in Blood by Coagulation assay
2270
16899
1.59
57.18
7.6
8.2
inr
1.2
1.2
3.25
751
4975
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5031
45951
2.20
54.54
16.0
13.1
mg/l
19.3
22.7
12.56
4264
36118
(3000494) Fungus identified in Specimen by Culture
907
5373
1.83
53.91
1.9
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
210
677
3.19
51.21
1.8
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
3159
25724
1.54
51.00
4.3
4.8
mmol/l
6.5
6.7
6.04
2967
24014
(40760892) CBC W Ordered Manual Differential panel - Blood
1513
10460
1.62
50.56
5.0
4.5
—
—
—
0
0
(4015189)
69
91
7.67
49.20
2.9
2.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1893
13865
1.56
49.08
2.7
2.6
u/l
56.2
57.8
0.51
1719
12872
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
66
83
8.04
48.99
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3614
30541
1.54
47.35
4.5
4.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
374
1702
2.29
46.01
2.1
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
738
4345
1.81
44.08
3.3
3.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3660
31238
1.52
43.83
3.5
3.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
822
5013
1.75
43.49
1.4
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1302
8957
1.60
43.26
1.6
1.5
g/l
2.3
2.4
1.52
912
5645
(3009343) pH of Capillary blood
491
2544
2.02
43.23
3.3
3.4
ph
7.4
7.4
0.81
76
314
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
496
2581
2.01
43.14
3.3
3.4
kpa
5.1
5.2
0.32
453
2399
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3962
34454
1.55
42.97
8.0
7.6
u/l
75.6
76.8
0.84
3727
32619
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
477
2452
2.04
42.92
3.2
3.4
mmol/l
1.3
1.7
1.85
361
1820
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
342
1549
2.29
42.50
1.9
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
167
535
3.19
41.16
3.8
2.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
961
6221
1.66
40.54
1.3
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
572
3207
1.88
39.78
2.6
2.8
e9/l
4.0
4.1
0.58
433
2592
(3002179) Metamyelocytes/100 leukocytes in Blood
602
3433
1.85
39.67
3.7
4.0
%
0.6
0.6
0.16
151
761
(3041096) Erythrocytes [Presence] in Urine by Automated
1638
12080
1.51
39.05
3.1
3.0
—
—
—
0
0
(44813793)
116
304
3.88
38.88
1.1
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
146
447
3.33
38.76
2.2
2.5
e9/l
1.4
1.2
1.96
80
272
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
113
293
3.92
38.45
2.2
2.7
e9/l
0.2
0.2
0.41
95
257
(3048689) Calprotectin [Mass/mass] in Stool
882
5664
1.66
38.17
2.7
2.4
ug/g
143.1
130.6
0.40
677
4530
(3021440) Promyelocytes/100 leukocytes in Blood
615
3573
1.81
38.07
3.8
4.2
%
0.1
0.2
0.35
185
975
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
339
1604
2.19
37.83
3.5
3.6
mmol/l
24.8
24.8
0.08
314
1489
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3989
35136
1.50
37.08
4.5
3.9
pmol/l
14.7
14.7
1.02
3605
32374
(3037522) Nuclear Ab [Titer] in Serum
978
6489
1.62
37.05
1.4
1.4
titre
466.0
543.9
0.61
197
1329
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
293
1323
2.28
36.62
3.1
2.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
113
304
3.77
36.51
2.3
2.6
e6/l
513.5
540.5
0.21
94
259
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
81
170
4.82
36.18
5.5
4.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2585
21093
1.43
35.37
4.0
4.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
627
3757
1.76
34.79
3.8
4.2
%
0.8
0.9
0.67
188
1057
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4594
41902
1.61
34.76
5.4
4.6
mu/l
1.8
2.2
2.52
4194
38864
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
47
60
7.89
34.46
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
367
1856
2.05
34.37
3.4
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
575
3374
1.79
34.26
3.8
4.3
%
0.0
0.3
1.17
160
814
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
975
6576
1.59
34.21
2.1
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
3343
28658
1.43
34.17
4.5
4.1
e6/l
36.0
1460.4
4.51
66
381
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2426
19658
1.42
34.04
3.0
2.8
ug/l
119.7
124.3
0.47
2211
18408
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1100
7657
1.55
33.52
1.3
1.3
u/ml
10.0
11.3
0.25
393
3121
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3679
32148
1.44
33.45
3.4
3.1
u/l
46.0
47.3
0.40
3401
30324
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2754
22863
1.41
33.43
5.9
6.3
umol/l
10.6
11.2
1.82
2561
21753
(3023103) Potassium [Moles/volume] in Serum or Plasma
5017
46954
1.84
33.05
16.2
14.8
mmol/l
4.0
4.0
1.55
4890
45776
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1144
8062
1.53
32.86
1.3
1.3
iu/ml
24.4
31.0
1.27
320
2567
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
69
138
5.05
32.62
1.1
1.0
u/ml
2.5
4.7
0.92
14
18
(3019550) Sodium [Moles/volume] in Serum or Plasma
5000
46780
1.81
32.51
16.1
14.6
mmol/l
139.7
139.7
0.06
4875
45690
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
141
476
3.01
31.83
2.2
2.1
mg/l
21.7
21.4
0.03
43
128
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2243
18095
1.41
31.43
2.5
2.2
nmol/l
78.1
76.1
2.88
1998
16537
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2332
19046
1.39
29.89
5.3
6.2
mmol/l
1.2
1.2
8.85
2046
17390
(3019309) Folate [Moles/volume] in Red Blood Cells
1024
7231
1.51
28.66
1.9
1.7
nmol/l
1164.7
1158.2
0.08
765
5582
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1347
10076
1.45
28.10
1.7
1.7
mg/l
0.9
1.1
1.08
979
7650
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4550
41906
1.51
27.67
5.7
5.4
mmol/mol
39.3
39.4
0.34
4188
39254
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1348
10114
1.44
27.58
1.3
1.3
u/ml
1.8
1.8
0.05
365
2810
(40761511) CBC panel - Blood by Automated count
5096
48282
1.83
27.14
15.5
12.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
109
351
3.15
26.73
1.8
2.2
%
12.1
14.4
1.23
58
149
(3003338) MCHC [Mass/volume]
3647
40199
0.72
26.53
17.3
16.5
g/l
333.1
333.0
0.25
3634
39947
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1671
13098
1.40
26.49
2.3
2.1
u/l
148.6
219.9
5.09
1559
12364
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
141
530
2.70
26.16
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
141
531
2.70
26.07
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
142
537
2.69
26.04
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
143
545
2.67
25.83
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
140
528
2.69
25.81
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
141
539
2.66
25.32
1.5
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
260
1307
2.04
24.71
1.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1198
8971
1.43
24.30
1.7
1.6
pmol/l
6907666.4
31050294.2
2.06
970
7620
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2491
21018
1.34
24.03
6.3
6.9
mmol/l
1.2
1.2
7.18
1936
17854
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
248
1245
2.04
23.66
2.4
2.0
mg/l
9.3
11.1
3.32
232
1167
(3007461) Platelets [#/volume] in Blood
5336
51609
2.46
23.29
22.9
19.2
e9/l
260.2
252.9
14.09
5247
50469
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
349
1978
1.82
23.14
2.4
1.9
u/l
39.8
39.3
0.19
325
1779
(3023368) Bacteria identified in Blood by Culture
1430
11148
1.38
22.72
4.2
4.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
5335
51643
2.41
22.38
22.7
19.1
pg
30.3
30.3
1.08
5268
51035
(3024731) MCV [Entitic volume]
5335
51643
2.41
22.38
22.8
19.1
fl
90.8
90.8
0.03
5268
51037
(3010813) Leukocytes [#/volume] in Blood
5336
51662
2.41
22.29
23.0
19.2
e9/l
6.9
6.7
15.45
5237
50392
(3026361) Erythrocytes [#/volume] in Blood
5335
51651
2.40
22.23
22.9
19.2
e12/l
4.6
4.5
1.69
5234
50393
(3013005) Retinol [Moles/volume] in Serum or Plasma
71
196
3.66
22.22
2.4
1.6
umol/l
1.8
2.0
1.26
65
184
(3000963) Hemoglobin [Mass/volume] in Blood
5335
51661
2.40
22.05
23.0
19.3
g/l
137.3
136.9
1.20
5269
51045
(3012501) Base excess in Blood by calculation
201
972
2.11
21.21
4.2
4.3
mmol/l
2.1
2.5
1.60
141
661
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
199
961
2.11
21.08
1.4
1.4
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
26
30
8.70
20.64
1.7
1.6
mg/l
3.0
1.6
0.41
14
22
(3004616) Nuclear Ab [Presence] in Serum
135
559
2.45
20.61
1.4
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
167
760
2.24
20.54
1.6
1.5
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
62
165
3.79
20.48
1.8
2.2
%
12.1
8.7
1.21
57
152
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5148
49352
1.75
20.36
11.4
10.0
u/l
27.1
27.4
0.71
4959
47844
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
96
337
2.88
20.34
1.9
2.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
211
1056
2.04
20.32
1.8
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
137
577
2.41
20.16
1.5
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2192
18490
1.31
19.85
4.6
5.0
g/l
35.7
35.9
0.86
2004
17287
(3008757) Leukocyte morphology finding [Identifier] in Blood
111
427
2.63
19.76
3.5
4.0
—
—
—
0
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
3.1
1.6
—
10
20
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
3.3
2.9
0.09
15
23
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
4.8
4.8
0.01
16
20
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
5.0
2.1
0.66
16
20
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
2.2
2.3
0.03
16
18
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
1.6
1.9
0.14
16
21
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
0.9
0.6
0.34
14
20
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
1.3
0.9
0.13
16
22
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
25
29
8.66
19.76
1.6
1.6
mg/l
2.1
1.4
0.22
12
24
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
236
1245
1.94
19.57
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
190
928
2.09
19.56
3.8
3.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
27
35
7.75
19.53
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
149
661
2.29
19.50
1.5
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1356
10700
1.36
19.43
2.3
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
419
2627
1.64
19.28
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
138
596
2.35
19.22
1.6
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2029
17002
1.31
19.05
3.5
3.5
—
—
—
0
0
(3010421) pH of Blood
220
1144
1.96
19.04
4.0
4.2
ph
7.4
7.4
0.16
199
956
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1333
10519
1.35
19.03
2.5
2.2
mg/l
2.8
2.9
0.19
1155
9057
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1370
10892
1.34
18.53
2.8
2.9
ng/l
885.0
1214.5
2.74
1099
9205
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
515
3434
1.55
18.27
3.8
4.0
mmol/l
1.2
1.2
0.14
438
3019
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
162
767
2.15
18.10
1.9
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
69
217
3.21
17.72
2.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
69
217
3.21
17.72
2.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
69
217
3.21
17.72
2.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
69
217
3.21
17.72
2.0
1.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
234
1276
1.87
17.57
1.1
1.1
u/ml
4.6
5.8
0.13
20
172
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
200
1037
1.96
17.48
1.9
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
796
5848
1.42
17.35
1.2
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
101
400
2.55
17.01
1.8
2.4
%
39.9
42.3
0.21
17
50
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
58
168
3.48
16.97
2.1
2.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
52
140
3.74
16.95
2.8
3.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
57
166
3.46
16.55
2.1
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
57
166
3.46
16.55
2.1
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
102
412
2.50
16.50
2.6
3.5
%
57.7
57.2
0.09
74
259
(40767503) Oxygen content in Capillary blood by calculation
176
893
2.00
16.38
2.6
2.4
%
17.1
16.4
1.27
95
440
(3029937) Albumin [Presence] in Urine by Test strip
1424
11574
1.31
16.11
3.8
3.8
estimate
0.0
0.0
0.37
656
3960
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
228
1269
1.83
16.06
2.0
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4674
44247
1.39
15.79
4.2
3.8
mmol/l
1.3
1.3
0.42
4243
41191
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4833
46027
1.43
15.69
4.7
4.3
mmol/l
4.8
4.7
3.04
4416
43269
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4890
46674
1.45
15.65
5.0
4.7
mmol/l
2.8
2.8
0.77
4446
43618
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4809
45769
1.42
15.55
4.7
4.2
mmol/l
1.5
1.5
1.84
4379
42839
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
245
1413
1.77
15.34
1.5
1.7
g/l
0.2
0.2
0.61
237
1336
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
148
723
2.08
15.30
1.1
1.1
au/ml
8.2
11.6
—
7
49
(3047007) Chlamydophila sp Ab [Presence] in Serum
138
664
2.11
14.86
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
443
3001
1.52
14.56
1.7
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
249
1468
1.73
14.45
1.5
1.7
g/l
1.2
1.2
0.33
240
1389
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4597
43558
1.35
14.14
13.1
12.0
ml/min/173m2
84.9
84.4
1.18
4025
36080
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
88
359
2.48
14.00
1.2
1.2
u/ml
72.4
42.9
—
5
32
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
147
741
2.01
13.99
1.4
1.4
u/l
24.6
26.7
0.32
119
612
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4668
44361
1.36
13.87
4.8
4.3
mmol/l
5.8
5.9
3.06
4206
41044
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
138
684
2.04
13.76
1.1
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
138
684
2.04
13.76
2.6
3.4
%
0.9
1.5
2.12
107
526
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1979
17030
1.25
13.67
2.0
1.9
pmol/l
101.6
96.2
4.59
1069
9032
(3003327) Ova and parasites identified in Stool by Light microscopy
255
1538
1.69
13.63
2.1
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
663
4909
1.40
13.63
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1666
14061
1.27
13.57
2.3
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
302
1906
1.62
13.53
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
217
1254
1.76
13.53
1.4
1.4
ug/g
299.1
280.1
0.63
115
719
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
90
379
2.40
13.38
1.8
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
90
379
2.40
13.38
1.8
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
90
379
2.40
13.38
1.8
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
793
10169
0.74
13.06
3.6
3.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2491
22076
1.24
12.94
3.4
3.4
estimate
0.0
0.0
0.59
649
3967
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1086
8739
1.30
12.80
1.6
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
65
240
2.73
12.68
1.7
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
80
329
2.45
12.55
2.4
2.6
e6/l
722.3
699.3
0.13
51
137
(3045424) Erythrocytes [Presence] in Urine
144
750
1.94
12.52
1.3
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
47
147
3.22
12.28
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
111
531
2.11
12.21
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2453
21792
1.23
12.17
3.4
3.4
estimate
0.0
0.0
1.08
656
3989
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
64
240
2.69
12.14
1.7
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2457
21851
1.23
12.00
4.5
4.6
estimate
0.0
0.0
0.39
669
4114
(3021960) Folate [Moles/volume] in Serum or Plasma
1137
9305
1.28
11.63
1.6
1.5
nmol/l
20.0
20.4
0.51
938
8048
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
97
455
2.15
11.25
2.1
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1662
14262
1.24
11.21
2.7
3.4
mmol/l
2.3
2.4
2.52
1408
12643
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
19
31
6.15
11.19
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
450
3234
1.43
10.92
3.0
2.6
e9/l
68.4
70.2
0.60
359
2433
(1761868) Lipid panel - Serum or Plasma
2044
17970
1.22
10.82
2.9
2.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
67
274
2.46
10.70
1.7
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
39
119
3.29
10.65
1.6
2.2
e6/l
248.8
169.5
0.86
16
62
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
121
629
1.94
10.64
1.1
1.1
g/l
1.4
1.5
1.25
108
569
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
83
375
2.23
10.58
6.2
3.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
201
1220
1.67
10.56
1.2
1.3
u/ml
4.2
5.4
0.16
15
124
(3037692) Legionella sp identified in Specimen by Organism specific culture
44
146
3.03
10.47
1.6
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
174
1019
1.73
10.44
2.6
3.1
mmol/l
24.6
24.8
0.21
153
887
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
409
2915
1.44
10.39
3.4
3.4
pmol/l
4.5
4.5
0.02
362
2619
(3017446) Testosterone [Moles/volume] in Serum or Plasma
511
3787
1.39
10.37
2.4
2.2
nmol/l
13.3
13.1
0.29
439
3389
(3026493) Urate [Moles/volume] in Serum or Plasma
1405
11921
1.24
10.37
2.5
2.5
umol/l
1227.4
4019.6
5.03
1200
10503
(3047181) Lactate [Moles/volume] in Blood
216
1344
1.63
10.31
3.6
6.9
mmol/l
1.3
1.3
0.23
189
1177
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
100
493
2.05
10.22
2.1
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
201
1234
1.65
10.12
1.2
1.3
u/ml
2.2
8.2
2.98
27
198
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
264
1733
1.55
10.06
2.2
2.2
u/l
5941.3
4934.1
0.20
85
691
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
214
1339
1.62
10.00
1.2
1.3
u/ml
79.0
37.7
—
6
86
(3027945) Reticulocytes/100 erythrocytes in Blood
582
4433
1.35
9.93
2.7
2.6
%
1.7
1.8
1.15
501
3963
(3002523) Influenza virus A Ag [Presence] in Specimen
143
803
1.80
9.93
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
143
803
1.80
9.93
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
229
1460
1.59
9.91
1.7
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
69
297
2.34
9.88
1.6
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
75
337
2.24
9.72
1.7
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
69
301
2.31
9.59
1.6
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
485
3610
1.38
9.58
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
154
894
1.74
9.56
2.2
2.1
g/l
133.4
130.5
0.74
120
644
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
444
3265
1.39
9.44
1.2
1.2
iu/ml
126.2
152.3
0.83
182
1219
(3019420) Tryptase [Mass/volume] in Serum or Plasma
59
243
2.44
9.33
1.3
1.6
ug/l
8.6
8.2
0.06
49
215
(3012494) Peanut IgE Ab [Units/volume] in Serum
36
114
3.17
9.30
1.1
1.1
u/ml
0.3
1.5
0.81
21
57
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
54
214
2.54
9.26
1.6
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
35
970
0.36
9.20
5.5
3.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
525
6817
0.75
9.11
2.7
2.8
e6/l
1.9
2.5
1.63
290
3616
(3026389) Candida sp identified in Specimen by Organism specific culture
112
599
1.89
9.11
1.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1682
14696
1.21
9.08
5.1
4.5
ug/l
2.1
2.4
1.45
1499
13336
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
67
296
2.28
9.07
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
223
1446
1.57
9.01
1.9
1.6
iu/ml
0.2
5.4
0.68
33
292
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
262
1765
1.51
8.89
1.5
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
864
7053
1.27
8.79
3.5
3.5
mmol/l
0.8
0.8
1.84
797
6636
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
162
980
1.67
8.69
1.2
1.2
—
20.8
—
0
14
(3015171) Extractable nuclear Ab [Units/volume] in Serum
270
1841
1.49
8.65
1.2
1.3
u/ml
0.7
1.2
0.64
23
160
(3028626) Oxygen [Partial pressure] in Capillary blood
147
872
1.70
8.49
3.5
2.8
kpa
8.7
8.2
3.04
130
801
(3032057) Clostridioides difficile [Presence] in Stool
26
71
3.67
8.43
1.7
2.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
111
608
1.84
8.42
1.8
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
759
6131
1.28
8.40
2.2
2.5
g/l
2.4
2.3
2.55
685
5724
(3008536) Aspergillus sp Ab [Presence] in Serum
29
86
3.38
8.33
1.5
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
578
7315
0.77
8.29
2.6
2.6
e6/l
0.8
1.0
0.96
345
4085
(3008898) HLA-B27 [Presence]
255
1736
1.49
8.25
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
814
6646
1.26
8.24
2.2
2.5
umol/l
39.2
13.6
0.50
739
6208
(3021901) Oxygen saturation in Capillary blood
126
724
1.76
8.17
2.5
2.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
311
2211
1.43
8.04
1.1
1.1
titre
74.0
177.7
—
5
63
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
93
490
1.91
7.97
1.9
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
123
2060
0.59
7.88
3.5
3.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
62
284
2.20
7.76
5.0
3.4
mu/l
30.5
26.6
0.30
62
273
(21494814) CD8 cells/100 lymphocytes in Specimen
48
197
2.45
7.71
1.8
2.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
158
983
1.63
7.65
1.2
1.2
u/ml
1.3
4.9
—
9
74
(3015183) Erythrocyte sedimentation rate
57
255
2.25
7.56
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
89
474
1.89
7.41
1.2
1.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
48
203
2.38
7.25
1.8
2.1
%
8.9
8.5
0.06
48
197
(3004588) Protein electrophoresis panel - Serum or Plasma
365
2718
1.37
7.22
2.1
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
402
3040
1.35
7.20
1.2
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
521
4096
1.30
7.10
2.4
2.3
g/l
0.2
0.2
0.12
493
3840
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
696
5693
1.26
6.89
2.3
2.6
%
23.0
23.7
0.50
569
4931
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
92
508
1.82
6.88
1.6
1.6
%
53.3
57.4
0.37
58
317
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
40
161
2.50
6.74
2.1
1.7
u/ml
1207.5
23995.0
—
8
21
(3036670) Protein [Mass/volume] in Synovial fluid
30
104
2.90
6.72
1.3
1.2
g/l
40.4
38.3
0.24
12
61
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
331
0.21
6.71
13.9
13.1
nmol/l
507.3
843.9
—
7
315
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
416
3196
1.33
6.71
2.9
2.8
ng/l
115.2
162.7
2.94
381
2877
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
19
49
3.89
6.70
1.2
1.1
u/ml
0.5
0.0
—
9
31
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
10
14
7.15
6.69
1.1
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
324
4314
0.74
6.62
2.5
2.5
u/l
35.2
49.0
0.64
274
3725
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
141
891
1.60
6.47
1.5
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
217
3068
0.70
6.39
3.1
3.2
kpa
4.7
4.7
0.08
210
2967
(3000850) Epithelial cells [#/volume] in Urine
1048
9019
1.20
6.30
2.6
2.5
e6/l
5.4
5.7
0.17
938
7904
(3024891) Influenza virus A+B Ag [Presence] in Specimen
178
1194
1.51
6.27
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1370
12106
1.18
6.05
1.7
1.6
mmol/l
1.4
1.4
0.46
1076
10274
(3009214) Lutropin [Units/volume] in Serum or Plasma
202
1403
1.46
6.00
1.4
1.3
u/l
10.7
9.6
0.48
168
1154
(3047352) Trisomy 18 risk [Likelihood] in Fetus
44
920
0.47
5.96
1.4
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
421
5323
0.77
5.93
7.1
7.5
mmol/l
104.8
104.4
1.03
404
5210
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
229
1633
1.42
5.91
1.9
2.0
ug/l
2.2
2.4
0.08
196
1480
(3033658) Prothrombin time (PT) actual/Normal
997
11491
0.84
5.84
3.5
4.0
%
93.8
91.9
1.94
962
11204
(3025018) Bordetella pertussis Ab [Titer] in Serum
54
264
2.06
5.82
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
50
238
2.11
5.78
1.7
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
51
245
2.09
5.76
1.7
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
47
947
0.49
5.73
1.4
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
19
55
3.46
5.72
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
64
335
1.92
5.71
1.9
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
45
916
0.49
5.66
1.4
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
99
596
1.67
5.56
1.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1013
8790
1.19
5.50
1.6
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
551
4505
1.25
5.47
1.9
1.7
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
23
78
2.96
5.40
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
23
78
2.96
5.40
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
23
78
2.96
5.40
1.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
169
1160
1.47
5.38
2.0
1.9
pmol/l
205.4
200.1
0.25
163
1099
(3008295) Osmolality of Serum or Plasma
79
452
1.76
5.34
1.3
1.4
mosm/kgh2o
280.1
280.2
0.01
68
358
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
69
381
1.82
5.25
2.1
2.0
nmol/l
20.4
18.7
1.02
63
359
(4035726)
479
3881
1.26
5.15
1.5
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
28
109
2.58
5.12
1.3
1.1
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
8
6
13.35
5.07
1.1
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
43
204
2.12
5.06
1.5
1.6
u/field
1.3
3.6
1.45
34
150
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
55
286
1.93
5.04
1.1
1.1
iu/ml
7.0
10.1
0.63
13
80
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
562
4647
1.23
5.04
4.0
4.5
u/l
223.5
242.1
2.82
529
4407
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
61
329
1.86
5.02
2.0
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
35
153
2.30
5.01
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
51
259
1.98
5.01
1.4
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
111
708
1.58
4.99
1.1
1.1
u/ml
1.6
3.1
2.60
57
345
(3044927) Protein electrophoresis panel - Urine
68
381
1.79
4.96
1.2
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
142
958
1.50
4.95
4.2
8.2
mmol/l
11.2
11.4
0.24
124
855
(3018572) Chloride [Moles/volume] in Blood
142
959
1.49
4.93
4.2
8.2
mmol/l
105.1
105.2
0.06
124
856
(3006442) Creatine [Moles/volume] in Serum or Plasma
60
325
1.86
4.88
1.6
1.5
umol/l
74.8
68.5
—
6
32
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
383
3042
1.28
4.87
1.3
1.3
au/ml
48.1
49.8
0.04
15
135
(3021589) Normoblasts [#/volume] in Blood
2174
20111
1.13
4.84
11.2
9.2
e9/l
0.0
0.0
2.60
1865
16476
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
24
91
2.64
4.64
1.2
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
35
159
2.21
4.61
1.9
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
102
1562
0.65
4.61
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
125
835
1.51
4.60
1.7
1.6
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
7
5
14.02
4.57
1.1
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
90
560
1.62
4.52
1.6
1.6
—
—
—
0
0
(4024509)
68
393
1.74
4.50
1.8
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
69
401
1.73
4.48
2.9
2.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
132
898
1.48
4.46
3.0
3.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
55
299
1.85
4.46
1.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
198
1451
1.38
4.45
2.7
3.3
g/l
0.3
0.4
0.29
66
637
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
278
2149
1.31
4.38
2.4
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1304
11731
1.15
4.35
4.4
3.9
%
20.7
21.7
1.36
595
5280
(3002385) Erythrocyte distribution width [Ratio]
3722
38667
0.88
4.34
16.6
15.9
%
13.6
13.6
0.08
3662
37888
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
198
1458
1.37
4.33
2.0
2.4
ug/l
250.8
551.9
2.59
176
1377
(3037756) Immunofixation for Serum or Plasma
117
782
1.51
4.32
1.6
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
299
3786
0.78
4.29
3.5
3.9
kpa
5.8
5.8
0.05
288
3673
(4034850)
100
1513
0.65
4.29
8.8
9.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
167
1197
1.41
4.29
3.1
3.6
mg/l
52.9
56.0
0.07
108
967
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
167
1197
1.41
4.29
3.1
3.6
mg/l
25.4
59.4
2.14
110
968
(3020630) Protein [Mass/volume] in Serum or Plasma
411
3348
1.25
4.25
2.4
2.6
g/l
66.6
66.8
0.11
373
3088
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
27
114
2.38
4.22
1.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
541
4544
1.21
4.18
2.0
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
274
3495
0.77
4.18
7.6
9.2
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
9
13
6.93
4.16
1.0
1.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
51
279
1.84
4.08
1.1
1.0
u/ml
0.7
0.7
0.01
17
60
(3041354) Potassium [Moles/volume] in Venous blood
18
455
0.39
4.08
4.3
2.3
mmol/l
4.1
4.0
0.18
18
447
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
133
1880
0.70
4.02
2.4
2.9
%
0.7
0.7
0.09
125
1799
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
161
1161
1.40
4.02
3.0
3.5
ratio
0.9
3.3
—
10
92
(3017704) Immunofixation for Urine
42
217
1.94
4.00
1.5
1.6
—
—
—
0
0
(3012565) Volume of 24 hour Urine
45
239
1.89
3.95
1.8
2.4
ml
2053.8
1985.7
0.19
40
218
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
613
5241
1.19
3.92
5.9
6.4
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
13
38
3.43
3.90
1.0
1.0
u/ml
0.1
0.1
—
7
16
(3015076) Soybean IgE Ab [Units/volume] in Serum
47
255
1.85
3.88
1.0
1.0
u/ml
0.8
2.4
—
5
36
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
23
94
2.45
3.87
1.4
1.5
ug/l
0.5
0.4
0.61
16
65
(3033705) Calcium.ionized [Moles/volume] in Venous blood
18
442
0.41
3.83
4.3
2.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
46
249
1.85
3.83
2.0
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
302
2407
1.27
3.80
1.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
86
555
1.56
3.77
1.2
1.3
nmol/l
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1386
12624
1.13
3.76
3.4
3.3
mg/l
573.2
399.6
0.52
815
8042
(3045414) Leukocytes [Presence] in Urine
256
2003
1.29
3.74
1.6
1.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
85
549
1.56
3.72
1.9
2.0
umol/l
8.8
7.1
0.34
56
393
(3049717) Cytology report of Urine Cyto stain
201
1524
1.33
3.69
2.7
2.5
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
15
50
3.01
3.68
1.0
1.0
u/ml
0.0
0.2
—
8
30
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
17
61
2.79
3.68
1.1
1.0
u/ml
0.2
1.9
—
10
38
(3019060) Gas panel - Arterial blood
332
2687
1.25
3.68
3.8
5.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
577
4936
1.19
3.67
2.0
2.0
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
14
45
3.12
3.64
1.1
1.2
mmol/l
9.5
5.4
—
6
26
(3026008) Bacteria identified in Urine by Culture
1297
11792
1.13
3.61
2.9
2.9
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
32
156
2.06
3.60
1.7
11.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
114
790
1.45
3.58
1.6
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
151
1101
1.38
3.57
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
40
212
1.89
3.57
1.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
240
1877
1.29
3.53
1.6
1.7
mg/l
4.0
3.7
0.18
185
1327
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
617
5330
1.18
3.51
1.6
1.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
400
3321
1.22
3.51
2.5
2.4
au/ml
26.4
23.6
0.16
22
205
(3009508) Creatinine [Moles/volume] in Urine
1496
13741
1.12
3.49
3.3
3.2
mmol/l
7.7
7.9
0.55
1213
11685
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
36
186
1.94
3.47
1.9
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
36
186
1.94
3.47
1.9
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
194
2522
0.76
3.46
2.9
3.3
g/l
131.9
130.2
0.49
181
2456
(3040151) Glucose [Moles/volume] in Capillary blood
72
457
1.58
3.42
4.6
19.7
mmol/l
7.1
7.2
0.10
64
384
(3020874) Milk IgE Ab [Units/volume] in Serum
48
274
1.76
3.40
1.1
1.0
u/ml
1.2
1.8
0.18
16
71
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
64
2.66
3.39
1.1
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
954
8537
1.14
3.38
3.2
2.8
ug/l
0.7
0.7
0.61
576
5357
(3046861) Legionella sp Ag [Presence] in Urine
9
18
5.01
3.36
1.0
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
308
3770
0.81
3.35
3.4
3.9
mmol/l
2.1
1.9
0.26
245
3066
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
48
276
1.75
3.33
2.7
2.7
%
43.5
40.5
0.44
27
90
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
118
837
1.42
3.30
2.6
3.2
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
6
7
8.58
3.26
1.2
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
13
43
3.03
3.24
3.2
2.2
mg/l
1.2
1.2
—
8
28
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
19
4.74
3.23
1.1
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
16
60
2.67
3.22
1.1
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4403
42944
1.13
3.19
13.7
13.9
%
41.0
40.3
6.56
3041
32598
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
15
5.34
3.19
1.1
1.8
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
27
132
2.05
3.06
1.1
1.2
%
101.8
87.6
1.05
13
68
(3032743) Legionella sp IgG Ab [Presence] in Serum
10
29
3.45
3.04
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
54
331
1.64
3.00
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
23
464
0.49
3.00
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
629
5515
1.16
2.98
2.0
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1433
13236
1.11
2.97
4.2
4.0
mg/mmol
10.3
9.3
0.13
839
8482
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
160
1218
1.32
2.93
2.9
3.3
mg/l
1.3
1.5
1.62
141
1137
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
122
891
1.38
2.92
1.7
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
10
30
3.34
2.90
1.0
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
135
2.00
2.89
1.1
1.1
%
91.7
87.8
0.36
12
70
(3011985) Renin [Units/volume] in Plasma
87
600
1.46
2.88
1.6
1.5
mu/l
80.8
49.9
0.63
74
537
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
26
129
2.02
2.85
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
36
202
1.79
2.76
1.4
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
64
418
1.54
2.76
1.2
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
12
42
2.86
2.74
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
18
78
2.31
2.74
1.3
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
21
421
0.50
2.72
3.7
3.1
mg/l
11.0
54.7
2.26
16
312
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
273
2245
1.23
2.69
2.4
3.3
u/ml
33.3
49.5
0.96
265
2159
(3034770) Mitochondria Ab [Titer] in Serum
171
1331
1.29
2.69
1.2
1.3
titre
624.0
1003.4
—
5
41
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
9
24
3.75
2.67
1.0
1.0
—
—
—
0
0
(4094501)
170
1326
1.29
2.64
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
10
32
3.13
2.64
1.4
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
32
176
1.82
2.63
2.1
2.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
131
986
1.34
2.63
1.2
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
64
424
1.52
2.61
1.4
1.4
pmol/l
56.4
139.1
0.62
26
134
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
33
184
1.80
2.60
2.8
3.1
mg/l
9.0
7.8
0.48
28
146
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
18
80
2.25
2.60
1.3
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
129
973
1.33
2.56
1.4
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
44
2.73
2.54
1.2
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
174
2193
0.79
2.52
9.1
10.5
mmol/l
24.7
24.3
1.39
160
2070
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
26
136
1.92
2.50
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
37
217
1.71
2.47
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
123
927
1.33
2.47
4.2
3.4
mg/l
22.5
25.5
0.36
60
560
(40758558) Short blood count panel - Blood
1060
11528
0.90
2.46
5.8
6.9
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
109
2.02
2.45
1.1
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
59
390
1.52
2.45
1.4
1.4
e6/l
14078.6
48805.3
1.12
30
272
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
337
0.47
2.42
1.6
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
8
22
3.64
2.36
1.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
7
17
4.12
2.36
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
87
1193
0.72
2.34
1.4
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
125
955
1.32
2.31
5.7
5.8
iu/ml
336.8
2152.0
0.62
15
145
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
79
561
1.41
2.30
1.3
1.4
pmol/l
289.8
287.3
0.02
59
416
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
17
78
2.18
2.30
3.2
2.7
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
10
35
2.86
2.30
1.0
1.0
u/ml
0.0
0.2
—
5
23
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
131
1008
1.31
2.30
1.2
1.3
u/ml
46.3
44.8
0.03
15
106
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
31
177
1.76
2.29
1.6
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
1342
12509
1.10
2.26
3.8
4.2
ph
7.4
7.4
0.49
401
2405
(3044889) 12 lead EKG panel
3280
31735
1.08
2.25
3.9
3.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
59
0.00
2.24
0.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
110
829
1.33
2.24
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
110
829
1.33
2.24
1.4
1.3
—
—
—
0
0
(4146454)
66
456
1.45
2.24
2.8
2.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
278
2339
1.20
2.23
1.7
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
352
3025
1.17
2.21
2.9
4.0
ng/l
71.9
90.0
3.64
303
2661
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
42
264
1.60
2.20
1.5
1.5
u/l
12.7
12.5
0.04
42
254
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
159
1987
0.79
2.19
3.0
4.3
mmol/l
24.1
24.2
0.05
140
1791
(3000475) Leukocytes [#/volume] in Synovial fluid
133
1034
1.29
2.18
1.6
1.7
e6/l
9475.1
13291.6
0.66
92
739
(3045788) Cell count panel - Pleural fluid
19
362
0.52
2.17
1.5
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
41
636
0.64
2.15
1.6
1.5
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
6
166
0.36
2.13
1.5
2.2
e6/l
457.0
661.8
—
6
122
(3024928) Oxygen saturation in Venous blood
65
918
0.70
2.12
2.3
3.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
182
1476
1.24
2.11
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
29
167
1.74
2.11
2.6
2.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
15
68
2.21
2.10
1.1
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
10
37
2.71
2.10
1.9
1.7
umol/l
44.2
45.7
—
10
37
(3030313) Adrenal Ab [Titer] in Serum
10
37
2.71
2.10
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
49
324
1.52
2.08
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
326
2801
1.17
2.07
2.4
2.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
41
630
0.65
2.07
1.4
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
167
1345
1.25
2.07
1.2
1.3
titre
97.5
154.9
0.49
12
115
(3016135) IgD [Mass/volume] in Serum
5
10
5.00
2.07
1.0
1.2
mg/l
26.3
95.3
—
5
10
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
56
383
1.47
2.03
1.3
1.2
titre
195.0
216.6
0.07
12
76
(3023410) Appearance of Cerebral spinal fluid
30
492
0.61
2.02
1.3
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
23
125
1.84
2.02
1.2
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
63
442
1.43
2.00
1.3
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
54
368
1.47
2.00
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
57
394
1.45
1.97
1.2
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1641
15522
1.08
1.93
3.2
3.3
u/l
30.4
35.2
2.44
1537
14805
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
11
45
2.45
1.92
3.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
78
577
1.36
1.85
5.6
6.7
mg/l
11.0
11.4
0.32
72
534
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
77
1030
0.74
1.83
1.2
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
198
0.45
1.83
3.4
2.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
32
198
1.62
1.83
2.7
3.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
64
879
0.72
1.81
1.8
1.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
43
286
1.51
1.81
2.0
1.5
u/l
4.8
7.0
2.21
38
247
(3001019) Free T4 and TSH panel - Serum or Plasma
326
2836
1.16
1.81
1.7
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
184
0.43
1.80
2.0
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
615
5579
1.12
1.78
4.7
6.3
mmol/l
1.0
1.0
0.34
576
5234
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
45
304
1.48
1.77
1.6
1.9
u/field
2.3
1.8
0.30
29
128
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
55
387
1.43
1.76
1.2
1.1
mg/l
271.3
287.2
1.10
47
351
(3044009) aPTT.lupus sensitive (LA screen)
10
41
2.44
1.75
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
33
209
1.58
1.73
1.3
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
36
233
1.55
1.72
1.3
1.6
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
54
381
1.42
1.71
1.1
1.1
mg/l
252.5
273.6
0.38
45
331
(3048879) Bone marrow aspiration report
21
118
1.78
1.69
1.2
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
24
141
1.71
1.67
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
16
83
1.93
1.64
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
28
173
1.62
1.63
1.3
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
140
1141
1.23
1.63
2.0
1.9
iu/l
4.6
4.6
0.01
62
434
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
303
0.56
1.62
1.2
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
451
0.64
1.62
1.4
1.5
e6/l
2329.1
2383.2
0.02
24
326
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
34
221
1.54
1.61
1.1
1.1
u/l
25.9
22.5
0.14
29
173
(44790047)
69
514
1.35
1.60
1.8
1.4
—
—
—
0
0
(44790048)
69
514
1.35
1.60
1.8
1.4
—
—
—
0
0
(44806118)
69
514
1.35
1.60
1.8
1.4
—
—
—
0
0
(44790049)
69
514
1.35
1.60
1.8
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
112
892
1.26
1.60
3.2
3.7
u/ml
144.6
618.0
0.93
99
821
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
55
395
1.40
1.60
1.1
1.1
mg/l
46.0
41.0
0.24
43
331
(3011648) Oxygen content in Venous blood
22
364
0.60
1.60
3.0
2.3
%
11.9
11.4
0.19
22
364
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
13
63
2.07
1.59
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1234
13073
0.93
1.56
1.5
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
296
2590
1.15
1.55
5.4
7.7
mmol/l
24.5
24.5
0.04
273
2414
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
60
440
1.37
1.55
3.7
5.0
u/ml
166.1
65.9
0.31
19
128
(3014111) Lactate [Moles/volume] in Serum or Plasma
326
3689
0.88
1.54
6.0
7.7
mmol/l
1.3
1.3
0.64
314
3557
(40768795) Lymph node Pathology biopsy report
57
415
1.38
1.54
1.2
1.2
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
43
0.00
1.52
0.0
9.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
270
2352
1.16
1.51
1.3
1.3
iu/l
26.3
28.8
0.68
236
2026
(3033799) Differential panel - Peritoneal fluid
6
141
0.42
1.51
2.7
2.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
27
2.59
1.51
1.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
146
1207
1.22
1.50
1.3
1.4
mg/l
571.9
518.5
0.40
138
1147
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
385
3440
1.13
1.49
2.1
2.3
ug/l
7.5
8.0
0.11
337
3088
(3012441) Differential panel - Pleural fluid
24
381
0.63
1.49
1.5
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
34
226
1.51
1.48
1.5
1.3
titre
20.0
71.0
—
6
20
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
129
0.39
1.48
11.2
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
129
0.39
1.48
5.6
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
140
1155
1.22
1.48
1.4
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
879
8194
1.09
1.48
3.5
3.5
ng/l
385.4
591.2
0.61
594
6022
(3028679) Herpes simplex virus Ab [Presence] in Serum
38
259
1.47
1.47
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
179
1513
1.19
1.47
1.9
2.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
87
1103
0.79
1.45
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
596
5463
1.10
1.45
1.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
271
2370
1.15
1.45
1.4
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
22
132
1.67
1.45
1.3
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
55
403
1.37
1.45
1.5
1.5
g/l
0.9
1.0
0.37
55
403
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
402
0.65
1.44
1.3
1.4
e6/l
8620.7
86307.5
3.00
16
237
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
893
8345
1.08
1.42
2.8
2.7
mosm/kgh2o
536.0
549.5
1.04
785
7128
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
39
270
1.45
1.41
1.6
1.4
u/ml
21.2
20.2
—
9
52
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
38
262
1.45
1.40
1.3
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
88
1108
0.79
1.40
1.3
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
46
2.18
1.39
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
74
571
1.30
1.39
1.2
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
88
1107
0.79
1.39
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
88
1106
0.79
1.38
1.3
1.4
—
—
—
0
0
(4281824)
31
457
0.68
1.38
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
23
142
1.62
1.38
1.3
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
26
397
0.65
1.37
1.4
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
20
324
0.62
1.37
1.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
139
1159
1.20
1.34
1.5
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
43
307
1.40
1.33
1.2
1.1
ratio
1.0
1.0
—
9
113
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
34
232
1.47
1.33
1.0
1.1
%
93.3
94.1
0.06
26
187
(3001556) Androgen free Index in Serum or Plasma
11
54
2.04
1.32
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
26
168
1.55
1.31
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
126
1044
1.21
1.31
1.6
1.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
14
76
1.84
1.29
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
200
1728
1.16
1.29
1.7
1.7
mu/l
291.1
293.7
0.03
178
1567
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
8
34
2.35
1.29
1.0
1.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
18
2.78
1.28
8.0
1.7
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
26
169
1.54
1.28
2.5
2.6
au/ml
43.3
143.7
—
5
26
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
176
0.51
1.28
1.1
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
11
55
2.00
1.27
1.4
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
146
1.58
1.25
1.1
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
26
170
1.53
1.25
1.5
1.5
pmol/l
14.4
14.9
0.22
21
146
(4211845)
32
219
1.46
1.25
2.7
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
29
423
0.68
1.24
3.3
3.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
19
115
1.65
1.24
1.1
1.2
—
228.6
—
0
7
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
25
2.40
1.24
1.3
1.0
—
—
—
0
0
(4038314)
6
25
2.40
1.24
1.2
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
9
45
2.00
1.23
1.1
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
249
2198
1.14
1.21
2.7
2.7
e6/l
0.2
0.3
1.31
240
2136
(3027273) Bicarbonate [Moles/volume] in Venous blood
166
1927
0.86
1.18
3.6
3.4
mmol/l
25.5
25.3
0.42
161
1862
(3014051) Protein [Presence] in Urine by Test strip
81
1004
0.80
1.17
2.1
2.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
8
39
2.05
1.15
1.0
1.2
u/l
9.0
18.1
—
8
39
(3017461) Flecainide [Moles/volume] in Serum or Plasma
5
20
2.50
1.15
1.8
1.3
umol/l
0.4
0.8
—
5
15
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
18
110
1.64
1.15
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
337
3726
0.90
1.14
1.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
108
1296
0.83
1.14
2.8
3.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
36
258
1.40
1.13
1.9
1.3
nmol/l
1.5
1.2
0.76
25
196
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
92
752
1.23
1.13
1.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
778
7305
1.08
1.12
1.5
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
183
0.55
1.11
1.1
1.1
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
5
21
2.38
1.09
1.0
1.4
%
1.3
1.3
—
5
21
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
695
0.77
1.09
5.0
5.4
umol/l
343.0
370.1
0.74
43
603
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
166
0.54
1.07
2.9
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
21
314
0.67
1.06
1.8
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
185
1621
1.15
1.04
1.5
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
15
90
1.67
1.03
1.0
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
34
2.06
1.02
1.3
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
60
1.84
1.02
3.2
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
88
729
1.21
0.98
1.4
1.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
27
190
1.42
0.96
1.3
1.1
ng/l
552.4
365.1
—
7
45
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
54
1.85
0.96
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
357
3269
1.10
0.96
1.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
82
677
1.21
0.95
1.2
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
37
1.89
0.94
1.0
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
39
294
1.33
0.94
1.1
1.1
nmol/l
2.6
7.8
1.06
11
63
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
128
1482
0.86
0.93
3.0
3.7
u/ml
2723.0
3591.2
0.10
113
1273
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
120
0.50
0.93
6.7
7.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
41
312
1.32
0.93
1.6
1.5
mmol/l
8.1
7.9
0.23
33
198
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
779
7372
1.07
0.92
1.5
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
12
196
0.61
0.92
1.1
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
261
1.34
0.91
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
126
1.51
0.91
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
42
322
1.31
0.91
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
17
110
1.55
0.90
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
17
110
1.55
0.90
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
17
110
1.55
0.90
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
17
110
1.55
0.90
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
63
1.75
0.90
1.4
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
61
492
1.24
0.89
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
12
71
1.69
0.88
3.7
3.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
61
493
1.24
0.88
1.1
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
24
169
1.42
0.87
1.7
1.7
—
—
—
0
0
(4198724)
15
229
0.65
0.87
1.1
2.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
24
334
0.72
0.86
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
195
1.39
0.86
1.9
1.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
128
1.49
0.85
1.2
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
12
72
1.67
0.85
1.2
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
76
632
1.21
0.84
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
245
2220
1.11
0.84
1.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
6
31
1.94
0.84
1.0
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
82
688
1.19
0.83
1.2
1.4
mmol/l
69.8
64.2
0.59
65
557
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
111
0.54
0.83
1.3
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
140
0.57
0.82
1.6
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
46
1.74
0.82
1.3
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
65
1.69
0.82
1.4
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
122
1.48
0.80
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
201
1810
1.11
0.79
1.8
2.2
—
—
—
0
0
(3024316) Viscosity of Plasma
0
25
0.00
0.79
0.0
1.4
—
1.9
—
0
14
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
48
1.67
0.78
1.1
2.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
32
242
1.32
0.78
1.6
1.4
nmol/l
136.1
137.0
0.05
32
242
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
98
1.53
0.78
1.5
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
58
474
1.23
0.78
1.1
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
90
1.56
0.78
2.1
2.1
mmol/l
6.5
7.8
—
8
51
(40762365) Oxygen content in Arterial blood by calculation
13
82
1.59
0.78
3.2
2.7
ml/dl
15.7
14.9
0.55
13
77
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
27
0.00
0.77
0.0
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
544
5126
1.07
0.76
19.0
21.8
inr
1.3
1.3
0.16
147
779
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
99
1.52
0.75
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
50
404
1.24
0.75
1.3
1.6
promille
1.1
1.3
0.60
39
303
(4027681)
38
297
1.28
0.75
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
58
477
1.22
0.74
1.3
1.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
24
2.08
0.74
2.2
4.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
105
1206
0.87
0.74
2.4
2.2
g/l
38.6
37.9
0.53
91
1064
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
38
1.84
0.73
3.4
2.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
133
1.43
0.73
1.2
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
605
6384
0.94
0.73
1.6
1.8
%
1.4
1.4
0.09
515
5682
(3016750) Collection duration of Urine
34
263
1.29
0.72
2.3
2.2
min
486.6
493.7
0.23
23
195
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
89
764
1.17
0.72
1.2
1.1
iu/ml
17.3
12899.0
0.54
30
182
(3044242) Glucose [Moles/volume] in Arterial blood
14
207
0.68
0.72
1.8
2.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
121
1064
1.14
0.72
1.2
1.3
mmol/l
3.6
3.8
0.54
114
998
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
132
1489
0.88
0.71
2.2
2.2
%
92.1
91.7
0.07
119
1393
(3028707) Methadone [Presence] in Urine by Screen method
73
860
0.85
0.71
2.4
3.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
103
1181
0.87
0.71
2.6
2.2
g/l
0.0
0.0
0.06
97
1099
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
30
229
1.31
0.71
1.1
1.1
miu/ml
1286.9
1501.3
0.55
30
229
(3024471) HLA-A [Type]
11
170
0.65
0.70
1.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
50
409
1.22
0.69
2.0
2.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
27
1.85
0.68
2.6
3.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
10
61
1.64
0.68
1.0
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
47
383
1.23
0.67
1.3
1.3
mmol/l
12.2
12.4
—
6
105
(3018677) aPTT in Platelet poor plasma by Coagulation assay
693
6609
1.06
0.67
2.1
2.2
s
29.0
29.7
4.31
659
6418
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
92
0.54
0.67
4.0
2.9
u/l
65.0
2106.6
—
5
83
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
51
420
1.22
0.66
1.3
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
5
93
0.54
0.66
1.2
1.9
ug/l
1.9
1.9
—
5
46
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
19
136
1.40
0.66
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
22
162
1.36
0.66
1.5
2.0
mg/l
8.5
9.3
0.29
15
136
(3024932) HLA-DR beta [Type]
11
167
0.66
0.65
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
280
3020
0.92
0.65
1.9
2.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
44
1.59
0.65
2.0
2.0
—
—
—
0
0
(4268621)
42
515
0.81
0.64
2.7
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
211
1932
1.10
0.64
1.8
2.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
128
0.62
0.63
1.3
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
219
2383
0.92
0.63
1.5
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
344
3674
0.93
0.62
2.1
2.5
ml/min/173m2
73.1
69.2
1.13
160
1386
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
63
534
1.18
0.62
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
199
0.70
0.61
2.1
2.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
8
50
1.60
0.61
1.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
18
130
1.39
0.61
1.2
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
8
51
1.57
0.60
1.9
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
12
80
1.50
0.59
1.7
1.4
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
13
89
1.46
0.58
1.2
1.3
%
120.5
106.4
0.80
13
83
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
78
679
1.15
0.57
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
213
1967
1.09
0.56
1.8
2.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
213
1971
1.08
0.54
1.9
2.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
239
0.75
0.54
1.6
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
141
1551
0.91
0.54
2.8
2.3
g/l
3.7
3.8
0.61
100
1132
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
141
1550
0.91
0.53
2.8
2.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
78
684
1.14
0.53
1.8
1.3
u/l
22.8
40.7
1.29
70
598
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
39
1.54
0.53
2.2
2.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
62
1.45
0.53
1.1
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
211
1955
1.08
0.52
1.9
2.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
86
969
0.89
0.51
2.4
2.0
nmol/l
0.9
0.8
0.60
73
814
(3016018) Differential panel - Cerebral spinal fluid
60
518
1.16
0.51
1.3
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
41
1.46
0.50
1.2
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
82
727
1.13
0.48
3.2
2.7
u/ml
379.4
1391.9
0.91
11
40
(3035933) Granulocytes/100 leukocytes in Blood
19
145
1.31
0.48
1.3
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
46
1.52
0.48
1.0
1.3
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
13
93
1.40
0.48
2.2
3.3
u/l
81.9
117.6
—
8
30
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
58
667
0.87
0.47
1.3
1.3
mmol/l
7.7
7.3
0.27
42
500
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
124
1361
0.91
0.47
3.0
3.3
u/ml
0.4
0.3
1.60
81
765
(4133840)
18
137
1.31
0.47
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
182
1.26
0.46
1.2
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
24
191
1.26
0.46
1.2
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
40
338
1.18
0.45
1.9
1.8
mmol/l
6.3
6.6
0.47
31
229
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
34
283
1.20
0.44
1.1
1.1
u/l
1.0
1.1
0.50
21
136
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
110
999
1.10
0.44
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
123
1344
0.91
0.44
1.6
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
113
1239
0.91
0.43
4.7
4.5
mmol/l
3.8
3.9
1.63
105
1164
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
143
1551
0.92
0.43
2.8
2.3
g/l
7.2
7.3
0.32
109
1181
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
1436
0.92
0.43
2.7
2.3
g/l
10.0
10.3
0.35
108
1241
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
108
982
1.10
0.43
1.2
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
127
0.71
0.43
1.1
3.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
127
0.71
0.43
1.1
3.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
174
0.75
0.43
1.2
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
31
1.61
0.43
1.2
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
34
285
1.19
0.42
1.4
1.6
u/l
11.4
6.0
0.66
15
148
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
26
212
1.23
0.42
1.6
1.6
nmol/l
5.1
6.4
0.15
19
170
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
509
4892
1.04
0.41
1.8
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
167
1.26
0.41
1.1
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
17
0.00
0.40
0.0
8.9
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.4
—
2.0
—
0
17
(3042733) HLA Ab [Presence] in Serum
13
172
0.76
0.40
2.2
4.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
18
227
0.79
0.40
1.2
2.9
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
8
61
1.31
0.39
1.9
1.9
mmol/l
2.4
2.9
—
8
54
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
145
1561
0.93
0.38
1.3
1.3
miu/ml
170.1
219.2
1.32
78
738
(3002173) Hemoglobin [Mass/volume] in Arterial blood
379
3959
0.95
0.38
7.1
9.1
g/l
126.9
122.6
3.56
356
3818
(3041806) Other cells [#/volume] in Blood by Manual count
17
133
1.28
0.38
1.6
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
9
66
1.36
0.38
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
112
0.71
0.37
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
35
300
1.17
0.36
5.9
6.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
63
564
1.12
0.35
2.6
2.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
124
0.73
0.35
3.2
1.3
—
—
—
0
0
(4306422)
83
756
1.10
0.35
1.3
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
54
606
0.89
0.34
2.9
3.0
nmol/l
0.8
0.8
0.13
39
464
(43055442) Apixaban [Mass/volume] in Serum or Plasma
6
45
1.33
0.33
1.3
1.3
ug/l
120.7
118.6
—
6
37
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
15
118
1.27
0.33
1.3
1.4
%
43.9
31.9
—
7
75
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
144
1349
1.07
0.32
2.3
2.6
g/l
3.8
3.6
0.62
135
1279
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
459
4746
0.96
0.31
6.3
8.1
kpa
5.1
5.1
0.17
424
4539
(21494434) Karyotype in Bone marrow
41
361
1.14
0.31
1.2
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
52
1.35
0.31
1.1
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
459
4745
0.96
0.31
6.3
8.1
kpa
12.2
12.6
0.69
428
4536
(3017143) Hepatitis C virus Ab [Presence] in Serum
582
5653
1.03
0.31
1.4
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
76
830
0.91
0.31
1.1
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
54
1.30
0.30
1.1
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1172
11941
0.98
0.30
3.0
3.0
e6/l
0.3
0.4
0.27
925
8923
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
55
1.27
0.30
1.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
55
1.27
0.30
1.3
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
24
203
1.18
0.29
1.4
1.5
%
1.5
3.7
—
6
48
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
250
1.16
0.29
1.3
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
124
1323
0.94
0.29
2.8
2.4
g/l
1.3
0.9
0.24
104
1167
(3023183) Ammonium ion [Moles/volume] in Plasma
92
991
0.93
0.28
4.2
3.0
umol/l
30.7
36.0
1.50
76
856
(3022493) Free Hemoglobin [Mass/volume] in Plasma
22
186
1.18
0.27
4.0
5.4
mg/l
81.8
1325.9
0.49
13
132
(3020779) Urea [Moles/volume] in Serum or Plasma
394
3811
1.04
0.27
6.7
8.1
mmol/l
8.2
9.3
2.02
371
3655
(3020891) Body temperature
157
1658
0.95
0.27
4.7
4.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1189
11687
1.02
0.27
2.9
3.0
—
—
—
0
0
(44806071)
8
64
1.25
0.27
1.0
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
411
4240
0.97
0.26
6.6
8.6
%
96.0
95.9
0.26
390
4088
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
38
338
1.13
0.26
1.0
1.1
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
5
71
0.70
0.26
1.0
1.1
pmol/l
—
5.6
—
0
11
(3013293) Extractable nuclear Ab [Presence] in Serum
5
75
0.67
0.25
1.4
1.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
73
1.23
0.25
1.2
1.8
ng/l
80.3
139.4
—
9
73
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
184
1756
1.05
0.25
1.6
1.9
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
177
1688
1.05
0.24
4.2
5.8
%
1.8
1.7
0.74
158
1573
(3029396) Erythrocyte agglutination [Presence] in Blood
13
105
1.24
0.24
3.2
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1323
13038
1.02
0.24
3.1
3.1
e6/l
54.6
102.0
1.32
1064
9980
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
12
96
1.25
0.24
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
38
340
1.12
0.24
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
25
217
1.15
0.24
1.1
1.1
iu/ml
123.9
175.6
1.08
25
217
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
77
1.17
0.24
1.1
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
169
0.83
0.23
1.5
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
228
2371
0.96
0.23
1.9
1.9
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
38
1.32
0.23
2.0
2.5
u/field
0.4
0.6
—
5
38
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
31
275
1.13
0.23
1.2
1.2
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
39
1.28
0.23
1.0
1.1
—
3.4
—
0
5
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
50
457
1.09
0.22
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
92
865
1.06
0.21
1.9
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
175
1677
1.04
0.21
4.2
5.9
%
1.0
0.9
2.29
156
1566
(3002079) Sodium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
126.8
—
0
10
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
10
0.00
0.21
0.0
1.2
—
178.4
—
0
10
(40768800) Prostate Pathology biopsy report
91
856
1.06
0.21
1.2
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1517
15350
0.98
0.21
3.4
3.6
e6/l
58.0
87.0
1.25
1162
10803
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
98
1.22
0.21
2.1
2.2
umol/l
14.0
17.1
0.51
12
98
(40768441) Liver Pathology biopsy report
40
363
1.10
0.21
1.3
1.4
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
266.9
—
0
13
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
10
80
1.25
0.20
1.1
1.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
4.3
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
14
0.00
0.20
0.0
5.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
50
541
0.92
0.19
1.2
1.1
%
92.8
96.7
0.58
45
512
(3044941) Cell count panel - Synovial fluid
66
705
0.94
0.19
1.5
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
167
1736
0.96
0.18
2.0
2.1
s
21.5
21.5
0.01
136
1507
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
43
396
1.09
0.18
1.4
1.5
%
40.3
31.6
0.61
23
244
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
1459
0.96
0.18
2.8
2.3
g/l
2.9
3.1
1.43
105
1160
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
60
1.17
0.17
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
79
835
0.95
0.17
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
34
311
1.09
0.16
4.1
2.4
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
8
70
1.14
0.16
1.5
1.9
pmol/l
59.4
37.0
—
8
59
(3003396) Base excess in Arterial blood by calculation
464
4731
0.98
0.16
6.2
8.1
mmol/l
1.2
1.0
0.86
345
3700
(3045716) Anion gap in Serum or Plasma
17
193
0.88
0.15
2.9
2.6
mmol/l
8.4
9.6
—
7
147
(3011288) Drugs identified in Urine by Screen method
137
1319
1.04
0.15
2.6
3.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
24
266
0.90
0.15
2.8
3.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
15
130
1.15
0.15
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
101
1056
0.96
0.15
2.7
2.4
ug/min
114.3
116.7
0.02
56
661
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
24
216
1.11
0.15
2.7
2.3
umol/l
60.1
54.2
0.33
19
179
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
77
731
1.05
0.15
1.2
1.1
%
113.2
116.0
0.43
64
670
(40757373) Influenza virus identified in Isolate
9
79
1.14
0.15
2.7
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
203
0.89
0.15
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
40
371
1.08
0.15
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
40
371
1.08
0.15
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
40
371
1.08
0.15
1.1
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
83
1.08
0.14
2.6
1.2
—
—
—
0
0
(3036603) Volume of Urine
32
294
1.09
0.14
1.7
1.5
ml
1940.0
1989.2
—
5
60
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
7
86
0.81
0.14
1.0
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
236
2303
1.03
0.13
7.6
11.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
50
471
1.06
0.13
1.1
1.1
u/l
55.4
60.3
0.37
28
320
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
111
1150
0.96
0.12
1.7
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
93
967
0.96
0.12
1.4
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
23
210
1.10
0.12
1.7
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
66
690
0.96
0.11
1.3
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
160
1643
0.97
0.11
1.5
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
530
5231
1.01
0.11
2.5
2.8
umol/l
7.0
7.9
0.43
443
4569
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
18
198
0.91
0.10
3.4
3.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
39
368
1.06
0.10
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
39
368
1.06
0.10
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
93
961
0.97
0.10
1.3
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
738
7452
0.99
0.10
2.3
3.0
mmol/l
2.4
2.4
0.79
643
6538
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
39
369
1.06
0.09
1.1
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
28
262
1.07
0.09
1.3
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
938
9450
0.99
0.08
3.7
3.8
kg/l
1.0
1.0
0.38
179
1355
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
73
0.82
0.07
2.3
2.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
76
1.05
0.07
1.0
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
97
946
1.03
0.07
1.1
1.2
u/ml
328.5
268.2
0.96
50
604
(3019832) Treponema pallidum Ab [Presence] in Serum
441
4450
0.99
0.06
1.6
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
75
770
0.97
0.06
1.4
1.2
u/ml
5.9
3.5
0.34
23
250
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
111
0.90
0.06
3.5
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
43
414
1.04
0.06
1.9
1.3
nmol/l
1.5
1.4
0.22
36
374
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
105
1072
0.98
0.06
1.4
1.5
e6/l
5695.0
1306.2
0.37
92
861
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
105
1072
0.98
0.06
1.3
1.4
e6/l
54.2
24.5
0.43
89
819
(3023511) Choriogonadotropin [Units/volume] in Urine
91
890
1.02
0.05
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
91
890
1.02
0.05
1.2
1.4
u/ml
99.3
116.1
1.32
31
176
(3010375) cycloSPORINE [Mass/volume] in Blood
25
237
1.06
0.05
30.6
24.4
ug/l
110.9
113.1
0.07
19
195
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
126
1282
0.98
0.05
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
22
208
1.06
0.05
1.1
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
29
303
0.96
0.05
1.0
1.0
ng/l
42.8
46.0
0.18
21
207
(40761535) Cells panel - Urine sediment
344
3469
0.99
0.05
3.4
3.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
20
189
1.06
0.04
1.9
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
20
189
1.06
0.04
1.9
1.6
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
26
272
0.96
0.04
1.5
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
73
714
1.02
0.04
1.3
1.4
nmol/l
0.3
0.4
0.37
55
568
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
29
301
0.96
0.03
1.0
1.0
ng/l
286.5
328.7
0.60
22
211
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
29
301
0.96
0.03
1.0
1.0
ng/l
773.3
723.8
0.22
23
205
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
76
746
1.02
0.03
1.4
1.2
u/ml
4.8
4.5
0.07
29
323
(3026250) Tacrolimus [Mass/volume] in Blood
23
220
1.05
0.03
25.4
33.7
ug/l
7.1
7.5
0.53
16
201
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
132
1335
0.99
0.03
2.5
2.4
%
172.6
188.0
1.26
122
1273
(21491868) Cryoglobulin [Mass/volume] in Serum
19
181
1.05
0.03
1.1
1.2
g/l
—
0.2
—
0
14
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
92
1.09
0.03
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
207
2053
1.01
0.03
1.5
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
37
360
1.03
0.03
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
112
1.07
0.03
1.3
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
24
231
1.04
0.02
1.5
3.3
ph
7.4
7.4
—
10
79
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
425
4234
1.00
0.02
3.2
4.2
ug/l
5.8
31.2
2.38
343
3389
(3038177) Helicobacter pylori Ab [Presence] in Serum
81
820
0.99
0.02
1.1
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
22
227
0.97
0.01
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
130
1291
1.01
0.01
1.2
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
12
126
0.95
0.00
1.2
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
39
384
1.02
0.00
1.1
1.1
—
27.2
—
0
5
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
54
538
1.00
0.00
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
76
758
1.00
0.00
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
178
1785
1.00
0.00
1.9
1.8
g/l
1.7
1.5
1.09
153
1542
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
22
216
1.02
0.00
1.2
2.5
umol/l
51.1
152.2
—
9
120
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
14
139
1.01
0.00
1.4
1.5
ug/l
7.6
8.7
0.73
14
139
(3029075) Extractable nuclear Ab panel - Serum
14
141
0.99
0.00
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
35
351
1.00
0.00
2.3
2.3
ml
684.3
618.2
0.47
24
239
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
1.0
—
1.7
—
0
7
(42529406) Shigella sp [Presence] in Stool by Culture
130
1300
1.00
0.00
1.2
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
52
0.96
0.00
1.4
2.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
67
0.90
0.00
8.8
9.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
89
1.01
0.00
2.7
2.5
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.4
—
0
5
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
5
0.00
0.00
0.0
2.2
—
2.6
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
37.2
—
0
6
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
2814.1
—
0
9
(3001218) Citrate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ETMOIDECTOMY – Ethmoidectomy
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).